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Abstract 
Background: Although many people prefer to die at home, few people die at home in 
Norway. We know little about sociodemographic characteristics of people who die at 
home, the extent of palliative end of life care provided by health care services and 
whether they enable people to die at home. 
Aim: Investigate individual characteristics of decedents, health care service utilization 
in the last three months of life and associations with dying at home.  
Method: Population-based registry data from the Norwegian Cause of Death Registry 
were linked with other Norwegian registries, covering all decedents in Norway within 
2012-2013, with data from the last 13 weeks before death. Paper 1 investigated 
individual sociodemographic factors and estimated potentially planned home deaths 
that occurred at home. In Paper 2, trajectories of home nursing services and 
admissions to short-term skilled nursing facilities were estimated. Potentially planned 
home deaths for deaths in all locations were also estimated. Paper 3 investigated 
follow-up from general practitioners, OOH services and hospitalizations. Associations 
with home deaths and factors of interest were estimated by regression analyses in all 
papers. 
Results: Overall, 15% of the total population (22% of the community-dwelling) died 
at home. We estimated that 24% of community-dwelling people (16% of total 
population) had deaths that were potentially planned to occur at home, regardless of 
actual location of death; nearly a third occurred at home. The most common causes of 
death at home were circulatory disease (35%) and cancer (22%). The predicted 
probability of dying at home increased with 39% when cause of death was 
symptoms/ill-defined and 9% for external causes of death but decreased with 12% for 
cancer compared to circulatory disease. In total, 18% of men and 12% of women died 
at home. There was a trend where younger decedents were more likely to die at home, 
ranging from a 39% predicted probability in people <40 years to 8% in those ≥90 
years. For the community-dwelling, we estimated four trajectories of home nursing 
services and four short-term skilled nursing facility trajectories. Almost half received 
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no home nursing. A quarter received a high level of home nursing; almost 7 hrs/wk. 
This was the only home nursing service trajectory associated with dying at home 
compared to hospital (aRRR 1.29). A fifth had decreasing home nursing and about 8% 
accelerating home nursing towards the end of life. Almost 70% had a low probability 
of having a short-term skilled nursing facility stay. Another 7% had intermediate 
probability, 16% escalating probability and 8% increasing probability of a short-term 
skilled nursing facility stay. Trajectories of increasing (aRRR 0.40), escalating (aRRR 
0.32) and intermediate skilled nursing facility (aRRR 0.65) were associated with 
reduced likelihood of dying at home. Almost half the people with causes of death that 
predicted a potentially planned home death followed the high home nursing service 
trajectory. Nearly all people with potentially planned home deaths followed the 
trajectory with low probability of skilled nursing facility stays. During the last 13 
weeks, 14% of the total population received ≥1 GP home visit, 43% ≥1 GP office 
consultations and 41% had GP interdisciplinary collaboration. A minority had OOH 
consultations, while hospitalizations escalated. During the last four weeks, 7% of 
patients (10% of community-dwelling) received ‘appropriate’ follow-up with ≥1 home 
visit when the GP had ≥1 interdisciplinary collaboration. GP home visits (1: 3%; ≥2: 
7%) and interdisciplinary collaboration (1: 2%; ≥2: 5%) increased the predicted 
probability of dying at home in a dose-dependent manner. Health care services where 
the person had to leave home, including GP office consultations, OOH consultations 
and hospitalizations reduced the predicted probability of dying at home. 
Conclusions and implications: Few people died at home and many home deaths 
appear to have been unplanned. At a population level, follow-up from GPs and home 
nursing services at the end of life may enable people to die at home. Our results imply 
that most people dying in Norway do not receive enough ‘appropriate’ follow-up to 
make a home death feasible. The potential for delivering palliative end of life care at 
home is not utilized. To enable more home deaths, we should start talking about our 
preferences regarding end of life care and place of death. The way forward must 
include both an individual and a system perspective to give dying people a real choice 
about where they spend the end of life.  
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Samandrag 
Bakgrunn: Få personar døyr heime i Noreg, sjølv om mange ønsker å vere heime i 
livets slutt. Me veit lite om kven som døyr heime, omfang av lindrande behandling frå 
helsetenestene og om dei aukar moglegheitene for å døy heime.  
Mål: Undersøke kva som karakteriserer dei døde, bruk av helsetenester i dei siste tre 
månader av livet og samanheng med heimedød. 
Metode: Populasjonsbaserte registerdata frå Dødsårsaksregisteret blei samanstilt med 
data frå fleire norske register for alle døde i Noreg i 2012-2013, med informasjon frå 
dei siste 13 vekene av livet. Artikkel 1 undersøkte individuelle sosiodemografiske 
faktorar og estimerte potensielt planlagde heimedødsfall som resulterte i heimedød. I 
artikkel 2, blei forløp av heimesjukepleie og korttidsopphald i sjukeheim i livets slutt 
estimert. Potensielt planlagte heimedødsfall for alle dødsfall, uavhengig av dødsstad, 
blei estimert. Artikkel 3 undersøkte oppfølging frå fastlegar, legevakt og 
sjukehusinnleggingar. Assosiasjonar mellom heimedød og faktorar av interesse blei 
undersøkt med regresjonsmodellar i alle tre artiklar. 
Resultat: Totalt døydde 15 % av alle personar heime (22 % av heimebuande). Me 
estimerte at 24% av heimebuande personar (16 % av alle døde) hadde dødsfall som 
potensielt var planlagt å skje heime, uavhengig av faktisk dødsstad. Nesten 1/3 døydde 
heime. Sirkulatorisk sjukdom (35 %) og kreft (22 %) var hyppigaste dødsårsaker 
heime. Predikert sannsyn for å døy heime auka med 39% når dødsårsaka var 
symptom/ubestemte tilstander og med 9 % for ytre årsaker, men minka med 12 % ved 
kreft. Til saman døydde 18 % av menn og 12 % av kvinner heime. Det var ein trend 
der yngre personar hadde høgare sannsyn for heimedød, frå 39% predikert sannsyn hos 
personar <40 år til 8 % hos dei ≥90 år. Me estimerte fire forløp av heimesjukepleie og 
fire forløp for korttidsopphald på sjukeheim for heimebuande personar. Om lag 
halvparten fekk inga heimesjukepleie. Ein fjerdedel fekk eit høgt timetal 
heimesjukepleie; nesten 7 timar per veke. Dette var det einaste forløpet som var 
assosiert med auka sannsyn for heimedød samanlikna med sjukehus (aRRR 1,29). Ein 
femtedel fekk minkande og rundt 8 % fekk akselererande heimesjukepleie mot slutten 
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av livet. Nesten 70 % hadde lågt sannsyn for korttidsopphald på sjukeheim. Vidare 
hadde 7 % intermediært sannsyn, 16 % eskalerande sannsyn og 8 % aukande sannsyn 
for korttidsopphald på sjukeheim. Forløp av aukande (aRRR 0,40), eskalerande (aRRR 
0,32) og intermediært (aRRR 0,65) sannsyn for korttidsopphald sjukeheim var 
assosiert med redusert sannsyn for heimedød. Nesten halvparten av personar med 
dødsårsaker som predikerte ein potensielt planlagt heimedød fekk eit høgt timetal 
heimesjukepleie. Nær alle med potensielt planlagt heimedød følgde forløp med lågt 
sannsyn for korttidsopphald på sjukeheim. I løpet av dei siste 13 vekene fekk 14 % av 
pasientar ≥1 heimebesøk frå fastlegen, 43 % hadde fastlegekonsultasjonar og 41 % 
hadde fastlegar som deltok i interdisiplinært samarbeid. Eit mindretal hadde 
legevaktkonsultasjonar, mens sjukehusinnleggingar eskalerte. I løpet av dei fire siste 
vekene fekk 7 % av pasientar (10 % av heimebuande) ‘adekvat’ oppfølging med ≥1 
heimebesøk frå fastlege der fastlegen også hadde ≥1 tilfelle med interdisiplinært 
samarbeid. Heimebesøk frå fastlege (1: 3 %; ≥2: 7 %) og interdisiplinært samarbeid 
(1: 2 %; ≥2: 5 %) auka predikert sannsyn for heimedød i eit doseavhengig forhold. 
Helsetenester der personar måtte forlate heimen, inkludert fastlegekonsultasjonar, 
legevaktkonsultasjonar og sjukehusinnleggingar, reduserte predikert sannsyn for 
heimedød.  
Konklusjon og konsekvensar: Få personar døde heime og mange heimedødsfall ser 
ut til å ikkje ha vore planlagt. På populasjonsnivå kan oppfølging frå fastlege og 
heimesjukepleie i livets slutt legge til rette for meir heimedød. Våre resultat indikerer 
at dei fleste døyande i Noreg ikkje mottar ‘adekvat’ oppfølging slik at heimedød blir 
eit realistisk alternativ. Potensialet for å tilby lindrande behandling i livets slutt heime 
er ikkje utnytta. For å gjere heimedød tilgjengeleg for fleire, må me begynne å snakke 
om preferansar for behandling og pleie i livets slutt, inkludert preferanse for dødsstad. 
Vegen vidare må innehalde både eit individ- og eit systemperspektiv for å kunne tilby 





The population worldwide and in Norway is aging, with more people living with 
comorbidity and disability for an extended period of time.1 This leads to increased care 
dependency in the final years of life for many. At the same time, changing family 
structures reduce the number of family caregivers.2 As a consequence, health care 
services must provide care for more people for a longer period, including at the end of 
life.  
As in many developed countries, dying is institutionalized in Norway.3, 4 In 2017, 
12.5% died at home, 51.9% in skilled nursing facilities and 30.3% in hospitals.3 The 
proportion of home deaths in Norway is low compared to most other developed 
countries (Table 1).3, 5-19 
Table 1. Percentage home deaths in developed countries. 
Country % home death Year 
Japan1 11 2014 
Norway1 13 2016 
Sweden1 18 2012 
Belgium2 23 2007 
Germany2 23 2011 
Scotland2 23 2010 
England1 24 2016 
Denmark1 24* 2017 
Switzerland2 27 2007-11 
France2 28 1992-99 
Singapore2 28 2012-15 
Canada1 30 2004 
Netherlands1 31 2003-06 
USA1 31 2016 
*Numbers from Denmark extracted from graph. 1Based on total population. 2Based on region or 
sample within country. 
 
Norwegian policies, such as the Coordination reform, have given municipalities a 
larger role in providing health care services to its inhabitants.20 This has led to a larger 
proportion of deaths taking place in skilled nursing facilities instead of hospitals in 
recent years, but has not led to  more deaths at home (Figure 1).3 While Belgium and 
Germany has had a similar development to Norway,7, 10 Canada, the UK and the US 
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have seen an increase in the proportion of people dying at home over the last 
decades.17, 21, 22 This may be due to policies and end of life services prioritizing home 
deaths for people who prefer to remain at home. 
Up until the start of this PhD project in 2014, limited research on palliative and end of 
life care in Norway was published, and there were considerable deficiencies in 
knowledge about both the quantity and quality of palliative care provided to 
community-dwelling patients.23, 24 Additionally, the vast majority of international 
literature was focused on cancer patients. This background section will introduce 
research related to dying at home, with literature acquired throughout the research 
period and an updated literature search completed in January 2020 for the writing of 
this thesis.  
 
 
Figure 1. Place of death 1986-2017 in Norway. 
Official statistics from the Norwegian Cause of Death Registry.3 Total number of deaths by location and 
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1.1 Dying at home 
1.1.1 Preferences 
Many have investigated where people prefer to die. Evidence summarized by Gomes 
et al. suggest that a majority of people in the general population, among patients and 
caregivers prefer a home death, and around 80% of patients do not change their 
preference for place of death with illness progression.25  However, there were large 
variations depending on study population, setting and methods used; e.g. with weaker 
quantitative evidence for older people.25 Qualitative research indicate that also older 
people prefer to remain at home, but they worry about burdening their family.25, 26 
Another review from Hoare et al. cautions that we do not know how many prefer to 
die at home, because of large proportions of missing data in published studies due to 
unreported preferences.27  
Family caregivers are important in fulfilling a patient’s preference for place of death. 
Fukui et al. found that adult people who were concerned about family caregiver 
burden and the influence of their death, were more likely to prefer institutional care to 
homecare.28 Another study found that dying in a preferred location was most likely 
when the patient and family agreed, but was more consistent with the family’s 
preference when they diverged for both cancer and non-cancer patients.29 Gerber et al. 
investigated the decision making process when determining preferences for location of 
death and found that it depended on the patient and caregivers’ personal history, how 
they dealt with uncertainty, and concerns for each other.30 Preferences were more often 
conditional in favoring one place over another, but flexible in accepting that it was not 
always achievable.30 To our knowledge, the preferences of the Norwegian population 
regarding place of care and death has not been investigated.  
1.1.2 Factors associated with dying at home 
Although many prefer to remain at home, this is not a realistic choice for all people who 
are nearing the end of life. Symptoms such as pain may become difficult to handle at 
home, or caregivers may become exhausted, which may lead to admission to an 
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institution being the best option at the time.31, 32 Both individual and system factors 
influence whether or not a person is able to die at home (Table 2). Whereas many 
individual factors are non-modifiable, system factors can be modified through changes 
in policies and access to health care services.  
Table 2. Factors associated with dying at home 
Individual Known preference 
 Advance care planning 
 Family caregiver 
 Caregiver coping 
 Not living alone 
 Ethnicity 
 High socioeconomic status 
 Cancer 
 Low functional status 
 Low comorbid disease burden 
System GP home visits 
 Home nursing 
 Multidisciplinary home palliative care 
 
For people who prefer to die at home, it is important to make their preference known. 
Advance care planning is a repeated communication process that “enables individuals 
to define goals for future medical treatment and care, to discuss these goals and 
preferences with family and health care providers, and to record and review these 
preferences if appropriate”.33 A known preference for home death is associated with 
dying at home, and may lead to improved quality of care.15, 34-37 Having a family 
caregiver and not living alone are also important elements, as both have been associated 
with dying at home.34, 35 Caregiver coping is also central.34 Other individual factors 
associated with dying at home include ethnicity, higher socioeconomic status, dying 
from cancer versus other illnesses, low functional status, lower comorbid disease 
burden, and living in more rural areas.15, 34, 35 The relationship with sex and age is more 
unclear, with varying results from different studies.15, 35, 38 Dying from cardiovascular 
disease has been associated with dying in other locations than home.34  
System factors associated with dying at home include receiving home visits from 
general practitioners (GPs), home nursing services and multidisciplinary home 
palliative care.34, 35, 39 On the other hand, hospital admissions in the last year of life and 
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admission to hospitals with palliative care services is associated with dying in another 
location than home.34 A Norwegian cluster randomized trial from 2000 provided a 
specialized palliative care intervention to cancer patients, and found that home death 
was more frequent in the intervention group (25%) compared to the control group 
(15%).40 However, time at home did not increase, and because of a shift from skilled 
nursing facilities to inpatient palliative care for some patients, hospital use was 
unchanged.40 Qualitative research indicates that hospitalizations at the end of life occur 
when end of life homecare is insufficient to meet patient needs or if the home is no 
longer considered to be appropriate.41  
1.2 Palliative and end of life care 
1.2.1 Definition 
A core value for palliative care has been to enable people to make choices about end 
of life care and place of death. The World Health Organization defines palliative care 
as “an approach that improves the quality of life of patients and their families facing 
the problem associated with life threatening illness, through the prevention and relief 
of suffering by means of early identification and impeccable assessment and treatment 
of pain and other problems, physical, psychosocial and spiritual.”42 Palliative care can 
be provided in addition to disease-modifying treatment, or become the total focus of 
care.43 Usually, palliative care becomes more important with illness progression. End 
of life care is an important part of palliative care, and usually refers to care in the final 
months of life for patients with progressive disease, impaired function and increased 
symptom burden.44  
1.2.2 Who needs palliative care? 
A white paper from the European Association for Palliative Care, states that palliative 
care is appropriate for anyone living with or at risk of developing a life threatening 
illness, when they have unmet expectations or needs, and are willing to accept care.43 
Access should not be restricted by sex, age, diagnosis or prognosis. In a cross-national 
study from 12 countries, Morin et al. estimated that 38-74% of people who died were in 
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need of palliative care.6 While the lowest estimate excluded people with a range of 
chronic conditions (stroke, ischaemic heart disease, multiple scleroris, non-Alzheimer 
dementia and diabetes) and thus probably underestimate needs, the upper estimate gives 
a more inclusive estimate of palliative care needs.6 The highest prevalence of palliative 
care needs were for people dying at home or in skilled nursing facilities.6 The World 
Health Organization has estimated that Europe has a population of about 560 per 
100,000 aged ≥15 years each year, who are in need of palliative care at the end of life.45 
This corresponds to >24,000 (60% of those who died) people aged ≥15 years in Norway 
in 2017 being in need of palliative care at the end of life.45-47 
Clinical diagnosis 
Traditionally, palliative care has been offered predominantly to people with cancer, but 
in recent years, more focus has been added on providing this service to people with 
chronic illnesses with limited survival, such as chronic heart failure, pulmonary, renal 
or neurological diseases, and dementia.48-51 Seow et al. found that while 88% of 
decedents with terminal illness (cancer) received palliative care, this was only the case 
for 44% of patients with organ failure and 32% of people with frailty within a universal 
health care system (Ontario, Canada).50 The terminal illness group also received 
palliative care at an earlier time and with higher intensity.50 The disparity of people 
dying from other conditions than cancer in accessing palliative care, is consistently 
documented.51-56 
Functional trajectories 
Differences in functional decline at the end of life and how readily the end of life can 
be predicted, may be contributing factors to why cancer patients receive more palliative 
care than people dying from other conditions. Four clinical trajectories have been 
proposed to explain functional decline for different groups of people at the end of life: 
1) sudden death, 2) terminal illness, 3) organ failure and 4) frailty.57 Terminal illness 
usually refers to people dying from cancer, with a clear terminal phase. Organ failure 
and frailty (e.g. dementia) on the other hand have a terminal phase that is considered 
more difficult to predict.58 Gill et al. however, found there was no predominant 
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trajectory of functional decline for older people in the last year of life relating to cause 
of death.59 The exception was dementia, where two thirds had persistently severe 
disability (similar to the frailty trajectory57) in the last year of life.59  
While the trajectories using clinical conditions estimate mean trajectories for predefined 
groups of decedents in a hierarchal model, Gill et al. used a group-based trajectory 
model, where they identified the functional trajectories first and then characterized 
members of each trajectory with regard to causes of death. Lunney et al. compared the 
two methods with analyses in the same population, and confirmed that clinical 
conditions did not adequately predict trajectory of functional decline at the end of life.60 
While the clinical trajectories highlight that different conditions require different 
approaches of health care services at the end of life, trajectories of functional decline 
clarify that many other factors influence functional decline at the end of life.60 Clinical 
condition should thus not be the only factor deciding access to palliative care.  
1.2.3 Identifying people in need of palliative end of life care 
Timely identification of people in need of palliative care is important to maximize 
benefit. There is no uniform way to objectively identify patients, and accurate 
prognostication is difficult.61 Trajectories of functional decline (above) may be of 
limited use in individuals. General indicators, such as increase in bedrest and increase 
in restricting symptoms may indicate that a conversation about palliative care and end 
of life preferences is appropriate. Both increase substantially around five months before 
death for older people dying of all causes.62, 63 Use of the surprise questions: “would I 
be surprised if this patient died within the next 6-12 months” has been proposed as a 
way to identify patients who might benefit from palliative care, especially in primary 
care by GPs. Reviews investigating the accuracy of this question alone, found large 
variability, with poor to modest performance in predicting death.64, 65   
Several diagnostic tools for identifying people in need of palliative care have been 
developed for use in general practice.66, 67 Many are built on each other, several include 
the surprise question, and all share common features such as general indicators for 
decline (e.g. functional status and hospital admissions) and disease specific indicators 
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for several conditions.66, 67 In most countries, however, identification of palliative care 
needs is still mostly based on the GPs clinical judgement and discharge information 
from secondary care.67-69 
1.3 Palliative care in primary health care 
1.3.1 Specialized and general palliative care 
Palliative care can be provided at a general or a specialized level. Specialized 
palliative care refers to health care professionals who mainly provide palliative care; 
often for patients with complex problems who require other treatment options than 
those provided in general palliative care.70 General palliative care is provided by 
health care professionals whose main focus of work is not palliative care, and requires 
good basic skills and knowledge in palliative care.70  
The need for palliative care services are expected to grow due to demographic changes 
with aging populations and more people living with chronic diseases.71 Although 
specialized community-based palliative care benefits patients and caregivers,39, 72-74 it 
is unavailable for many dying people.71, 75, 76 The need for palliative care is much 
larger than what specialized palliative can provide, even in high income countries.45, 77 
This has led to more emphasis on providing general palliative care in primary health 
care.71, 75  
A more sustainable model is probably that most community-dwelling patients nearing 
the end of life receive general palliative care from GPs, home nursing services and 
skilled-nursing facilities, while more complex cases are referred to specialized 
palliative care services.75, 77 This will require increased knowledge and skills for all 
involved health care personnel, improved continuity and coordination of care, and that 
inadequate policies and guidelines are adressed.75, 78, 79 Gomez-Batiste et al. has 
provided recommendations for policy for integrated general palliative care for people 
with all types of chronic conditions.80 This includes: 
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 How to address educational, organizational, and ethical challenges  
 Public health policy approach 
 All settings and services.  
1.3.2 General practitioners 
GPs may have a crucial role in providing general palliative end of life care to 
community-dwelling people, and increase the likelihood of their patients being able to 
die at home.31, 75, 81-84 They are in a strong position to offer such services due to long-
term relationships with their patients and often knowledge of the whole family and 
community. Patients and caregivers prefer holistic care from GPs at the end of life,84 
and more frequent GP home visits to patients at the end of life is also associated with 
increased caregiver satisfaction.85  
There are also large differences between GPs in performing home visits at the end of 
life. Up to on-in-four do not involve themselves in palliative care at all.86, 87 Barriers for 
GPs’ involving themselves in of end of life care include reported lack of time, limited 
available resources, having to make home visits, lack of knowledge and palliative care 
training, lack of interest, difficulty in recognizing palliative care needs, talking to 
patients about end of life care, and difficulty in predicting time of death.83, 87-91 However, 
programs for systematic quality improvement to enhance person-centered end of life 
care in primary care are being implemented for example in the UK and has led to 
improved outcomes for patients and caregivers.92 
Most research to date has been using self-report from GPs or mainly focused on cancer 
patients.31, 76, 83-86, 93-96 There is little knowledge on Norwegian GPs’ contribution to end 
of life care for their patients, and if the same mechanisms are working here.  
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1.3.3 Home nursing services 
Nurses constitute the largest group of health care professionals, but there is little 
research on whether home care nurses (district nurses) provide general palliative end 
of life care to community-dwelling patients, and if so, how they do it. Most of the 
available studies are qualitative with small sample sizes which capture what the nurses 
say they do, but not what they actually do, or how they impact outcomes.97, 98 A 
Canadian study of cancer patients found that home nursing was protective of 
hospitalization and emergency department visits in the last month of life, and end of 
life home nursing with an end of life intent (more resources) provided by regular home 
nurses, was protective in the last six months of life.99, 100 Home nurses may be the 
health care professionals who see the patient most often, and have a unique 
opportunity to care for patients also at the end of life. 
1.4 Organization of palliative end of life care in Norway 
1.4.1 The Norwegian health care system 
Norway has universal health care. Municipalities are required to offer health care 
services to its inhabitants and ensure that all have access to a GP and primary out-of-
hours (OOH) services. The central government is responsible for providing hospital 
services.    
Municipal health care services are based on needs, and offered to almost 7% of the 
population.101 This includes practical help in daily tasks, personal assistance, daycare, 
food delivery, personal safety alarm, home nursing, rehabilitation facilities, short-term 
and long-term skilled nursing facilities, but does not include GP or OOH services. 
Services are expanding due to increased longevity and more people requiring 
assistance with increasing age. In 2016, 47,647 people received long-term skilled 
nursing facility care, 67,430 received short-term skilled nursing facility care, and 
223,780 received home nursing.101 More than half (55%) of those who receive home 
nursing are living alone.24  
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Skilled nursing facilities have a deductible based on income, while home nursing 
services are free to the patient. GPs and outpatient clinics offer services for a fee, up to 
a maximum expenditure per year, currently 2085-2369 NOK (approximately 250 
EUR).102 Hospitalizations are free to the patient.  
Palliative care is organized into general and specialized palliative care (Figure 2). 
There is no medical specialization in palliative care, but around 65 physicians located 
both in primary and secondary health care have a certified palliative medicine special 
area of competence.103 Specialized palliative care is mainly provided to cancer patients 
both in hospitals and municipalities.48 Guidelines for palliative care are predominantly 
focused on cancer patients, except for a pediatric guideline for palliative care 
regardless of diagnosis.24, 48  
 
 
Figure 2. Palliative care services in Norway.24, 43, 104-106 





Hospital wards offer general palliative care to admitted patients. Specialized palliative 
care is provided in palliative centers with palliative inpatient units and/or outpatient 
clinics organized at a local or regional level; of which some provide home visits. 
Regional centers also work with research and development. Pain clinics may offer 
specialized pain treatment to palliative patients.24 Pediatric patients are mainly treated 
within pediatric units, where palliative care is focused on children with cancer.48  
1.4.3 Skilled nursing facilities 
All skilled nursing facilities offer general palliative care, and some also specialized 
palliative care. There were 48 palliative units within skilled nursing facilities in 2017 
with a total of 294 beds, and an additional 147 single palliative beds within regular 
skilled nursing facilities.24 Palliative units consist of ≥4 beds, they have more staff and 
a physician with competency in palliative care.24  
1.4.4 Home 
Community-dwelling people receive care from home nursing services, GPs and other 
municipal health care personnel in addition to family caregivers. 
Home nursing services 
Home nursing services offer general palliative care. Around 25% of workers are 
unskilled.107 Half of all municipalities have a cancer/palliative coordinator who work 
to improve care coordination and quality of life for community-dwelling patients with 
cancer and their caregivers.24, 48 There are no municipal specialized palliative teams, 
except one non-profit organization in Oslo (Fransiskushjelpen), which cares for 
community-dwelling cancer patients.24   
General practitioners 
There are around 4800 GPs in Norway.105  Almost all Norwegian citizens (99.8%) are 
registered with a GP.105 They offer continuity of care with long-term relationships and 
services during daytime and OHH.108 Reports about the GPs’ involvement in palliative 
care is variable, but indicate that more involvement in palliative patients may be 
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necessary.24, 48 The GP is required to perform home visits to patients who are unable to 
come to the GP clinic for consultations or when it is necessary to provide responsible 
health care.109 However, the number of home visits have decreased after 2012 (95 per 
1000 inhabitants in 2016), except for people ≥90 years.110 In general, home visits are 
mainly provided to the oldest population and in municipalities with <20,000 
inhabitants.110 Number of contacts for interdisciplinary collaboration increased until 
2014, before it started declining (97 per 1000 inhabitants in 2016).110  
Family caregivers 
Family caregivers are considered essential for persons who prefer to remain at home at 
the end of life. It is estimated that family caregivers’ care contribution (in all areas) 
equals around 100,000 full time equivalents.111 Unfortunately, the interaction between 
family caregivers and official health care services is often random or lacking.111 
Elderly people mainly receive care from official health care services and their spouse 
or partner, rather than their children.111 Family caregivers who want to care for a 
family member in the final stages of life, may receive compensation in form of an 
attendance allowance from the government.112 The allowance is limited to 60 days for 
each person nearing the end of life and can be divided between several family 
caregivers.  
1.5 Rationale of the thesis 
Dying at home is a complex issue, and dependent on many elements being in place at 
the right time. Studies from other countries are not necessarily generalizable to Norway, 
due to differences in culture, society and health care system. Some knowledge about 
specialized palliative care has been reported previously from Norway, but little is known 
about who dies at home and how primary health care services provide palliative end of 
life care to the population.  Many individual factors are non-modifiable, whereas system 
factors are modifiable through changes in policies and organization of health care 
services. Before we can improve services, we need knowledge about the services 





2. Aims of the thesis 
The overall aim of this thesis is to investigate individual characteristics of decedents, 
health care service utilization in the last months before death and associations with 
dying at home within the context of the Norwegian health care system. Registry data 
provides a population-based perspective on patterns of service utilization and 
individual characteristics of decedents. The three papers included in this thesis cover 
different aspects and contribute to the overall aim: 
Paper 1  
This paper aims to: 
 Investigate factors associated with dying at home compared to other locations 
 Estimate how many home deaths that may have been planned to occur at home 
 Investigate individual differences between people with potentially planned 
home deaths and where a home death appears not to have been planned 
Paper 2  
This paper aims to: 
 Investigate trajectories of nursing services in the last 13 weeks of life  
 Estimate how many deaths that potentially could have been planned to occur at 
home, regardless of actual place of death 
 Investigate associations between place of death, potentially planned home 
deaths and nursing service trajectories 
Paper 3   
This paper aims to: 
 Investigate patterns of patients’ contacts with GPs, primary care OOH services 
and hospitalizations in the last 13 weeks of life 
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 Investigate whether patients’ contacts with GPs (office consultations, home 
visits), GPs interdisciplinary collaboration, primary care OOH contacts and 
hospitalizations in the last 13 weeks of life were associated with dying at home 
 Investigate whether various GP contacts were associated with fewer OOH 
contacts or days hospitalized during the last 13 weeks of life 
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3. Materials and methods 
3.1 Data sources 
3.1.1 The Norwegian Cause of Death Registry  
The Norwegian Cause of Death Registry (NCoDR) records and produce national 
statistics on all deaths. NCoDR records cause of death and place of death for all 
Norwegian residents living in Norway or abroad, and all non-residents living in 
Norway.113, 114 Death certificates are completed by the physician who has examined the 
deceased person; usually the treating physician or an OOH duty physician. The death 
certificate goes through the local county court or police to the Chief municipal medical 
officer, before reaching the registry. NCoDR has a high degree of coverage and 
completeness, with medical information on >98% of all deaths. Two quality assessments 
have ranked NCoDR in the second-best group with “medium” and “medium-high” 
quality respectively, and one in the best-quality group. Use of unspecific codes lowered 
the score in all three assessments. Few validation studies have been conducted.113 Until 
2014, Statistics Norway was responsible for the registry, when the Norwegian Institute 
of Public Health was given full responsibility.113  Information from NCoDR was used 
in all three papers. 
3.1.2 The National Registry for Statistics on Municipal Health Care 
Services  
The National Registry for Statistics on Municipal Health Care Services (IPLOS) is a 
registry for statistics on municipal health care services administered by the Norwegian 
Directorate of Health.115 Since 2007 it has been the main data source for Norwegian 
municipal health care statistics. It is a pseudonymous register where service recipients 
can be followed over time without recognizing the specific individual. Exemptions for 
linkage with other data can be made, when the data provided to researchers remain 
anonymous. IPLOS has compulsory registration for all municipalities on all persons 
who apply for or receive municipal health care services. They register the person’s 
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resources, need of assistance and services provided. The information is generated from 
the journal and archiving systems which are in everyday use in the municipalities and 
does not require additional reporting. Data quality is assessed by comparison with 
information from other official statistics (KOSTRA – Municipality-State-Reporting) 
and reports are returned to the municipalities.101, 116 An internal quality assessment of 
the 2012 data registered in IPLOS shows few registration errors in measures included 
in this study.117 A research project to validate IPLOS regarding community-dwelling 
persons with cognitive impairment, found that IPLOS was well suited for assessing 
needs relating to activities of daily living, but less so when considering cognitive 
function.118 Information from IPLOS was used in Paper 1 and Paper 2.  
3.1.3 The Control and Payment of Reimbursement to Health Service 
Providers Database 
The Control and Payment of Reimbursement to Health Service Providers Database 
(KUHR) is owned by the Norwegian Directorate of Health. It is an administrative 
database that handles reimbursements from the Norwegian government to GPs, OOH 
physicians, other health care professionals and institutions.119 The database includes 
electronic billing claims, which make up >99% of all claims and is a reliable source.120 
Information reflects utilization of the above mentioned health care services in the 
population. One billing claim is made for every contact, and identifies contact type, the 
physician, the patient, diagnoses and specific fee codes. Information about the GPs from 
the General Practitioner Register was also provided by the Norwegian Directorate of 
Health, which allowed linkage between the GP and their registered patients. Information 
about GP and OOH contacts from the KUHR database was used in Paper 3. 
3.1.4 The Norwegian Patient Registry  
The Norwegian Patient Registry (NPR) is administered by the Norwegian Directorate 
of Health and contains data from the specialist health care services. This includes 
information on persons waiting on or who have received treatment in hospitals, 
outpatient clinics or from private specialist practitioners.121 Data completeness in 
reporting personal identification number for patients is mostly high with a few 
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exceptions, while knowledge about data quality is not sufficiently reported.122 
Information from areas with low completeness (private specialist practitioners, 
newborns in some health care regions) was not used in this project. Information from 
NPR was used in Paper 3.  
3.1.5 Statistics Norway 
Statistics Norway is an independent institution responsible for collecting and publishing 
official statistics about the Norwegian society, economy and population. Data come 
from several sources with yearly updates. They provide statistical data from several 
areas to researchers, such as family relationships, marital status, citizenship, place of 
residence and educational level.123 Statistics Norway work systematically with 
quality.124 We used data from Statistics Norway in Paper 3. 
3.2 Study population and design  
All three papers are based on individually linked data on all deceased individuals in 
Norway from 1 January 2012 to 31 December 2013. Information about 
sociodemographic data and health care utilization for each day of the last 13 weeks (3 
months) of life was collected retrospectively. An overview of data sources is given in 
Table 3.  
Table 3. Overview of studies, papers and registries/databases 
 Design NCoDR IPLOS KUHR NPR Statistics Norway 
Paper 1 Cross-sectional X X    
Paper 2 Longitudinal X X    
Paper 3 Longitudinal X (X) X X X 
NCoDR: The Norwegian Cause of Death Registry. IPLOS: The National Registry for Statistics on 
Municipal Health Care Services. KUHR: The Control and Payment of Reimbursement to Health 
Service Providers Database. NPR: The Norwegian Patient Registry. 
 
In Paper 1 we used a cross-sectional design. The study population consisted of all 
80,908 deceased people, excluding those with missing information about place of 
death (n=2521) or sex (n=5). Paper 2 had a longitudinal design and included all 
53,396 deceased community-dwelling people, excluding those with missing 
information about place of death (n=2521), sex (n=5) or who had a decision of long-
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term skilled nursing facility care (n=27,512). Day of death was set as day zero, and all 
events decremented for each day of the last 13 weeks. We used a longitudinal design 
in Paper 3. The study population consisted of all 80,813 deceased people. We 
excluded those with missing information about patient identification number (n=135), 
place of death (n=2484), or where country of residence was not Norway (n=15). All 
events were decremented each day from the day of death for 13 weeks.  
3.3 Measures 
Place of death 
Place of death was provided by NCoDR and a main outcome and grouping variable in 
all three papers. We categorized place of death into four categories: home, skilled 
nursing facility (long-term and short-term), hospital, and other location (abroad, under 
transportation to hospital, other). All three papers used this categorization for 
descriptive results. In Paper 1, we compared deaths at home, skilled nursing facilities 
and hospitals. Paper 2 used place of death as an outcome with four categories (above). 
Only short-term skilled nursing facility stays were used due to study inclusion criteria. 
In Paper 3, place of death was dichotomized into home and any other locations 
(skilled nursing facility, hospital, other). 
Potentially planned home deaths 
Although registry data cannot be used to estimate people’s preference for dying at 
home, we can differentiate sudden, unplanned home deaths from those where health 
care service utilization implied that resources were allocated to facilitate time at home. 
We can also differentiate people with causes of death that are known to have a higher 
probability of receiving palliative care and might accordingly focus on more time 
spent at home or a plan to die at home.48 Potentially planned home deaths were 
estimated based on information about municipal health care services (IPLOS) and 
cause of death (NCoDR), with slightly different criteria in Paper 1 and Paper 2.  
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Paper 1 – Estimate 1 
A home death was considered potentially planned to occur at home if a person 
received domiciliary care (municipal home nursing services or practical home-based 
services) at any time during the last 13 weeks of life and had a cause of death among 
those most likely to receive palliative care (Figure 3). These were according to the 
European Shortlist for Causes of Death: Cancer (2.), Circulatory disease (7.), 
Respiratory disease (8.), Kidney disease (12.1) and Neurological disease (6.1, 6.3).48, 
125 Dementia was not included in this group because almost everyone with dementia in 
Norway die in skilled nursing facilities.126 The remaining home deaths were 
categorized as unplanned to occur at home. 
 
Figure 3. Estimation of potentially planned home deaths used in Paper 1. 
Algorithm for estimating potentially planned and unplanned home deaths among people who died at home. 
 
Paper 2 – Estimate 2 
Although a person may have had a plan to remain at home towards the end of life or 
die at home, this does not necessarily end up transpiring, due to various circumstances. 
To account for this, we expanded the definition of potentially planned home deaths to 
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also include deaths that occurred in other locations (Figure 4). People in long-term 
care were considered highly unlikely to have a plan to die at home and excluded. We 
used a narrower definition of diagnoses most likely to receive palliative care. 
According to the European Shortlist for Causes of Death, this was Cancer (2.), Heart 
disease (7./7.1.2/7.2/7.4; excluding acute myocardial infarction), Chronic pulmonary 
disease (8./8.3/8.3.1/8.3.2/8.4), Kidney disease (12.1) or Neurological disease 
(6./6.1/6.3).48, 125 Receiving home nursing seven days before death was defined as the 
latest time of initiation of services compatible with receiving palliative end of life care 
at home.  
 
Figure 4. Estimation of potentially planned home deaths used in Paper 2. 
Algorithm for estimating potentially planned and unplanned home deaths among all community-dwelling 
people, regardless of actual place of death. 
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Municipal nursing services 
Information about municipal nursing services was based on service decisions provided 
by IPLOS and used in Paper 1 and Paper 2.  
In Paper 1, we defined domiciliary care as receiving municipal home nursing services 
or practical home-based services at any time during the last 13 weeks or not. Skilled 
nursing facility stays included both short-term and long-term stays and were defined as 
‘yes’ for anyone having a stay of any duration during the last 13 weeks, else ‘no’. 
Domiciliary care and skilled nursing facility stays were used as covariates. In Paper 2, 
home nursing services were estimated as mean hours per week (hrs/wk) for each of the 
13 weeks leading up to death and based on service decisions. Minimum value was zero 
hrs/wk for people who did not receive any home nursing in a particular week. 
Maximum value was set to 168 hrs/wk, which indicated a person received care around 
the clock. Short-term skilled nursing facility stays were classified as occurring or not 
for each of the thirteen weeks leading up to death.  
Contacts with general practitioners  
Information about contacts with GPs were provided by the KUHR database and used 
in Paper 3. We included 253,663 billing claims from GPs that were home visits or 
office consultations with patients, or contacts with other health care personnel 
regarding the patient during the last 13 weeks of life. GP contacts with other health 
care personnel is mainly with home nurses. We used it as an indicator of 
interdisciplinary collaboration, and as meaning that different health care professionals 
work together to achieve better patient care. Each contact type was used as a 
continuous variable and a categorical variable with counts per contact type (0, 1 or 
≥2). We defined receiving ≥1 GP home visit and ≥1 GP interdisciplinary collaboration 
as ‘appropriate’ follow-up at the end of life. 
Contacts with primary care out-of-hours services 
Contacts with primary care OOH services were provided by the KUHR database and 
used in Paper 3. We included 53,703 billing claims that were physician home visits or 
office consultations with patients during the last 13 weeks of life. Each contact type 
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was used as a continuous variable and a categorical variable with counts per contact 
type (0, 1 or ≥2).  
Hospitalizations 
Information about hospitalizations was provided by NPR and used in Paper 3. In total, 
45 hospital admissions were excluded because they were coded as starting after death. 
Discharge date was set to the day of death for 3923 hospital admissions coded as 
discharge after death. Hospitalization was used as a continuous variable counting total 
number of days spent in hospital during the last 13 weeks of life.  
Covariates  
Based on previous knowledge from other countries,35, 127-130 we selected relevant 
factors in relation to cause of death that was available in the registries and databases 
utilized.  
Table 4. Causes of death used in each of the three papers 
 Code Diagnoses 








Paper 2 EU shortlist Cancer (2.) 
Heart (7./7.1.2/7.2/7.4) 




Paper 3 ICD-10 Cancer (C00-D49) 
Circulatory (I00-I99) 
Respiratory (J00-J99) 
Dementia (F00-F03, G30) 
External (V00-Y99) 
Other (specified). 
EU Shortlist: European Shortlist for Causes of Death.125 ICD-10: The International Statistical Classification 
of Diseases, Tenth Revision.131 Codes in parenthesis refer to specific codes within the Classifications. 
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Cause of death was provided by NCoDR (Table 4). Cause of death was missing for 
242 individuals in Paper 3 and coded into ‘other’. Whether cancer was cause of death 
were used in regression analyses instead of all causes of death in Paper 3. 
Sex was provided by NCoDR and coded as male or female. Age was provided by 
NCoDR. In Paper 1 and Paper 2 age at time of death was divided into seven groups: 
0–39, 40–49, 50–59, 60–69, 70–79, 80– 89, 90 years. In Paper 3 age at time of death 
was given in 5-year intervals up to 104, then ≥105. 
Statistics Norway provided information about municipality population and centrality. 
Municipality population was missing for 285 individuals. It was classified as 0-2000; 
2001-5000; 5001-10,000; 10,001-50,000 and ≥50,001 and used in Paper 1.  
Municipality centrality was used in all three papers, and refers to a municipality’s 
geographic location in relation to a center with important functions, where 0 is least 
central (rural) and 3 is most central (urban).132 Municipality centrality was missing for 
285 individuals in Paper 1 and 2, and for 448 individuals in Paper 3. 
Statistics Norway provided information about education, which was used in Paper 3. 
Education specified highest completed education level: primary school, high school or 
college/university. An unknown education level was categorized as primary school 
(n=1422, 2.4%). 
In Paper 1 and Paper 2, IPLOS provided information about household, which was 
categorized as cohabiting or living alone. IPLOS coded people living in assisted living 
accommodation with separate apartments as living alone, while those living in long-
term skilled nursing facilities were coded as cohabiting.116 This variable was only 
available for the people registered in IPLOS and thus received municipal care, and was 
in total missing for 18,478 individuals. Statistics Norway provided information about 
marital status in Paper 3. Marital status was missing for 2 individuals. We defined 
marital status as ‘not married’ if a person was unmarried, widowed, divorced, 
separated, separated partner, divorced partner or surviving partner, and ‘married’ if a 
person was married or a registered partner at time of death. Number of living children 
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of the deceased at time of death was provided by Statistics Norway and categorized as 
0, 1 or ≥2. This covariate was used in Paper 3.  
3.4 Statistical analyses 
Descriptive statistics in relation to place of death were used in all three papers. 
Categorical variables were evaluated with Pearson Chi Square tests. Continuous 
variables were evaluated with median and 25th-75th percentiles. All three papers 
investigated factors associated with place of death in regression analyses. Marginal 
standardization (Stata margins and margins plot), which calculate absolute effects as 
predicted probabilities and differences in predicted probabilities of dying at home, are 
reported for regressions analyses results in the thesis which are not reported in the 
papers.133 Significance was accepted at the 5% level (p < 0.05) for all analyses in all 
three papers. All statistical analyses were conducted with STATA version 14 (Paper 
1) and version 15 (Paper 2 and Paper 3) (Stata Corp, College Station, TX). 
Paper 1 
Multinomial logistic regression was used to assess associations between place of death 
and sex, age, cause of death, municipality population, municipality centrality and 
domiciliary care. We repeated the analysis in the subpopulation of people who were 
registered in IPLOS to include type of household as covariate. Estimates were given as 
adjusted relative risk ratios (aRRR) with 95% confidence intervals (CI) and p-values. 
Logistic regression investigated differences between people with potentially planned 
home deaths versus unplanned home deaths in two separate models. In model 1, we 
adjusted for sex, age, municipality population, municipality centrality and skilled 
nursing facility. In model 2, we also adjusted for household in the population who 
were registered in IPLOS. Estimates were presented as unadjusted and adjusted odds 
ratios (OR) with CI and p-values.  
Paper 2 
We modeled development of home nursing services and short-term skilled nursing 
facility stays in the last 13 weeks of life simultaneously with a group-based dual-
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trajectory model using a Stata Traj plugin.134, 135 Group-based trajectory modeling is a 
semiparametric finite mixture model for longitudinal data using a maximum likelihood 
method.135 We used a censored normal distribution to model home nursing hrs/wk. 
The outcome was log transformed to normalize (log10(home nursing hrs/wk +0.1)). 
Short-term skilled nursing facility stays were modeled as the probability of being in a 
short-term skilled nursing facility each of the 13 weeks leading up to death with a 
Bernoulli distribution. Each outcome was modeled separately, then jointly. Model 
selection was done by adding one trajectory at a time followed by varying higher-order 
growth terms until an optimal fit was achieved. Optimal fit was evaluated by the 
Bayesian Information Criterion, average posterior probability of assignment (PPA) 
(≥0.9 considered excellent fit), odds of correct classification, the proportion with 
PPA<0.7 (indicated poor fit), and differences between predicted and observed group 
proportions.135 For meaningful interpretation, a group size of 5% of the population was 
considered a minimum.  
We used multinomial logistic regression to assess place of death and associations with 
potentially planned home deaths, trajectories of home nursing services and short-term 
skilled nursing facility stays. We adjusted for sex, age and municipality centrality. We 
repeated the analysis in the population registered in IPLOS to assess household as a 
possible confounder, without any indication of this being the case. Results were 
presented as aRRR with CI and p-values. 
Paper 3 
People receiving long-term skilled nursing facility care receive follow-up from nursing 
home physicians instead of their personal GP. Although they are not exposed to GP 
care, they remain on their personal GPs´ patients list. We generated the probability of 
being in long-term skilled nursing facility care with data from IPLOS and NCoDR, to 
account for people not exposed to GP care. Factors available in both datasets: age, sex, 
place of death, cause of death main categories by European Shortlist for Causes of 
Death,125 death certificate, death abroad, special circumstances, autopsy, and police 
report were used in the model after a stepwise backward selection. The model had 
excellent fit and prediction (receiver operating characteristic area 0.901 (CI 0.898-
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0.903)). We then used this predicted probability as a propensity score covariate in the 
models using the NCoDR/NPR/Statistics Norway/KUHR dataset.  
We used logistic regression to analyze associations between place of death (dying at 
home versus any other location) and factors of interest: number of GP home visits (0, 
1, or ≥2), number of GP consultations (0, 1, or ≥2), number of GPs contact with other 
health care services (0, 1, or ≥2), number of OOH home visits (0, 1, or ≥2), number of 
OOH consultations (0, 1, or ≥2) and days hospitalized. We adjusted for sex, age, 
whether cancer was cause of death, marital status, children, education, municipality 
centrality and probability of long-term skilled nursing facility care. We tested whether 
there was an effect of clustering of patients within GP by having a random effect of 
GP, but the intraclass correlation (ICC) of patients within GP was very small (ICC 
0.0014, SE 0.0057, CI 0.0000004-0.8111). Accordingly, we used a logistic regression 
model without clustering for GP with results presented as unadjusted and adjusted OR, 
CI and p-values. We used negative binomial multilevel mixed-effects analyzes in two 
separate models to estimate the association of GP home visits (0, 1, or ≥2), GP office 
consultations (0, 1, or ≥2) and GP interdisciplinary collaboration (0, 1, or ≥2) with 
number of OOH contacts (outcome 1) and days hospitalized (outcome 2). A random 
intercept for patients within GP was significant and included to account for clustering 
in both models. Covariates were sex, age, whether cancer was cause of death, marital 
status, children, education, municipality centrality, probability of being long-term in a 
skilled nursing facility and days hospitalized (model 1) or OOH contacts (model 2). 
Estimates were presented as adjusted incidence rate ratios (IRR) with CI, p-values, 
adjusted absolute numbers of OOH contacts and adjusted absolute number of days 
hospitalized. Due to lack of convergence, each cause of death was not included in any 
of the regression models.  
3.5 Ethical considerations 
The study was approved by the Regional Committee for Medical and Health Research 
Ethics North (2014/2308) and the Norwegian Data Protection Authority (15/00450-
2/CGN, 17/00341-3/SBO). Approvals for registry data and linkage were given by the 
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responsible authorities: the Norwegian Institute of Public Health (NCoDR), the 
Norwegian Directorate of Health (KUHR, NPR, and IPLOS) and Statistics Norway. A 
trusted third party performed linkage of data. Statistics Norway linked data from 
NCoDR and IPLOS and delivered anonymous data. The Norwegian Prescription 
Database136 linked data from NCoDR, KUHR, Statistics Norway and NPR and 
provided indirectly identifiable data to the researchers. Societal benefits were 





4. Main results 
4.1 Paper 1 
Over two years, 15.0% of the population died at home, 48.6% died in skilled nursing 
facilities, 33.3% in hospitals and 3.0% in other locations. In total, 12.2% of all women 
and 18.1% of all men died at home. Men had a 16.7% (CI 16.4, 17.1) predicted 
probability of dying at home in adjusted analyses, 2.4% (CI -3.0, -1.9) higher than 
women. There was a trend that predicted probability of dying at home decreased with 
increasing age (Figure 5).  
 
Figure 5. Predicted marginal probabilities of dying at home with respect to age 
Multinomial logistic regression analysis: postestimation predictive margins with 95% CIs for dying at 
home with respects to age, keeping everything else constant. 
 
Circulatory disease (34.9%) was the most common cause of death at home. The 
predicted probability of dying at home increased with 38.8% (CI 36.9, 41.6) when 
cause of death was symptoms/ill-defined and 8.9% (CI 6.9, 11.0) for external causes of 
death compared to circulatory disease. People dying from cancer had a 12.0% (CI -
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12.6, -11.4) reduced probability of dying at home compared to circulatory disease. 
People living in municipalities with fewer inhabitants were more likely to die at home, 
with those living in municipalities with 2001-5000 inhabitants having the highest 
probability (17.8%, CI 17.0, 18.7). Receiving domiciliary care was associated with a 
7.4% (CI 6.9, 7.9) increase in predicted probability, relative to not receiving 
domiciliary care. In the subpopulation of people who received municipal care, 
cohabiting reduced predicted probability of dying at home with 2.0% (CI -2.5, -1.5) 
relative to living alone.  
We estimated that 5089 deaths, 41.9% of all home deaths and 6.3% of all deaths were 
potentially planned home deaths that occurred at home. Men had a higher proportion 
of both potentially planned (51.7%) and unplanned home deaths (61.5%). Men had a 
5.9% (CI -4.1, -7.7) reduced predicted probability of a potentially planned home death 
in the adjusted analysis compared to women. In the population that received municipal 
care, women had 2.3% (CI -4.6, -0.1) reduced predicted probability of having a 
potentially planned home death, when also controlling for cohabitation. While 84.0% 
of cancer home deaths were potentially planned, this constituted only 10.2% of all 
cancer deaths. The proportion of potentially planned home deaths was 48.8% for 
circulatory disease, constituting 8.3% of all deaths from circulatory disease. 
Municipalities with <50,000 inhabitants were consistently associated with more 
potentially planned home deaths. The highest predicted probability was for 
municipalities with 5001-10,000 inhabitants (46.0%, CI 43.7, 48.4). For people who 
received domiciliary care, cohabiting increased predicted probability of having a 





4.2 Paper 2 
Out of 53,396 community-dwelling people, 22.2% died at home, 27.9% in a skilled 
nursing facility, 45.4% in a hospital and 4.5% in other locations. Men had a higher 
proportion of home deaths (58.0%). Cancer was the most common cause of death at 
home (22.1%) but constituted only 14.1% of all cancer deaths. Second most common 
was heart disease (20.7%), which constituted 28.9% of all deaths from heart disease.   
We estimated four clinically interpretable trajectories of home nursing services 
simultaneously with four short-term skilled nursing facility trajectories for the last 13 
weeks of life (Figure 6). Almost half the population followed a trajectory of no home 
nursing in the last three months of life. Nearly a quarter followed a trajectory with a 
high level of home nursing; almost 7 hrs/wk. This was the only home nursing service 
trajectory associated with dying at home compared to hospital (aRRR 1.29, CI 1.21, 
1.38) in the fully adjusted model. This corresponds to a 3.5% (CI 2.4, 4.5) increase 
compared to people who followed the trajectory of no home nursing. A fifth of people 
followed a decreasing home nursing trajectory, which was associated with a reduced 
likelihood of dying at home (aRRR 0.90, CI 0.83, 0.97) compared to hospital. 
Approximately 8% followed a trajectory of accelerating home nursing. We found no 
significant difference between home deaths and hospital deaths (aRRR 0.93, CI 0.85, 
1.03).  
Almost 70% had a low probability of having a short-term skilled nursing facility stay 
at the end of life. Another 6.7% followed a trajectory of intermediate probability, 
15.9% escalating probability and 8.4% increasing probability of a short-term skilled 
nursing facility stay. Trajectories of increasing (aRRR 0.40, CI 0.34, 0.47), escalating 
(aRRR 0.32, CI 0.28, 0.36) and intermediate skilled nursing facility (aRRR 0.65, CI 
0.59, 0.72) were all associated with reduced likelihood of a home death compared to 
hospital, relative to the trajectory with low probability of a skilled nursing facility stay. 
People following the increasing and escalating trajectories had a very low predicted 
probability of dying at home of 4.6% (CI 4.0, 5.3) and 4.4% (CI 3.9, 4.9), respectively. 
Predicted probability of home death was 18.5% (CI 17.2, 19.9) for the intermediate 
trajectory and 28.5% (CI 28.1, 29.0) for the low trajectory.  
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Figure 6. Home nursing service trajectories (A) jointly modelled with short-term 
skilled nursing facility trajectories (B) in the last 13 weeks of life. 
Solid lines represent predicted trajectories, dashed lines indicate observed trajectories. Percentage of 
population for each trajectory are shown in parentheses. A) On the y-axis, 0 corresponds to 1 hrs/wk of 
home nursing and 1 corresponds to 10 hrs/wk. 
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In total, 24.0% of deaths were estimated to be potentially planned home deaths, 
regardless of actual place of death. Actual place of death for these 12,790 potentially 
planned home deaths was 27.1% at home, 18.0% in skilled nursing facilities, 53.8% in 
hospitals and 1.0% in other locations. In the entire deceased population within 2012-
2013, this corresponded to 15.8% potentially planned home deaths, with 4.3% of all 
deaths being potentially planned home deaths occurring at home. Potentially planned 
home deaths were not associated with place of death in the fully adjusted model 
(aRRR 0.94, CI 0.89, 1.00).  
Almost half (11.3%) the people with causes of death that predicted a potentially 
planned home death followed the high home nursing service trajectory. Nearly all 
people with potentially planned home deaths followed the trajectory with low 
probability of skilled nursing facility stays; regardless of which home nursing service 
trajectory they followed. People with unplanned home deaths followed trajectories 











4.3 Paper 3 
Altogether, 14.3% of the population received ≥1 GP home visit, 42.7% ≥1 GP office 
consultations and 40.8% had GP interdisciplinary collaboration during the last 13 
weeks of life. Likewise, 12.0 received ≥1 OOH home visit and 20.0% had ≥1 OOH 
clinic consultation. People were hospitalized a median of four days (25th-75th 
percentile 0-14). Figure 7 shows how these contacts developed over the last 13 weeks 
of life.  
 
 
Figure 7. Contacts in the last 13 weeks of life.  
Percentage of all deceased with ≥1 of contact types: general practitioner (GP) home visit, GP office 
consultation, out-of-hours (OOH) home visit, OOH consultations and/or hospitalization each week in the 
last 13 weeks of life. 
 
During the last four weeks of life, 7442 people (9.2%) received ≥1 GP home visit 
(range 1-28), of which nearly a third (2.6%) died at home. Likewise, 6.6% of patients 
received ‘appropriate follow-up’ with ≥1 home visit when the GP had ≥1 



























receiving various health care services during the last 13 weeks of life. GP home visits 
and GP interdisciplinary collaboration were positively associated with dying at home 
compared to any other location in a dose-dependent relationship. 
 
Table 5. OR for dying at home compared to any other location of death (nursing 
home, hospital, other) and associations with contacts with GPs, OOH services and 
days spent in hospital during the last 13 weeks of life.  
 Adjusted 
OR 
(CI) p Predicted 
probability (%) 
(CI) 
GP home visit (ref. 0)      
 1 1.92 1.71, 2.15 <0.001 3.3 2.7, 3.9 
 ≥2 3.49 3.08, 3.96 <0.001 6.5 5.8, 7.2 
GP office consultation 
(ref. 0) 
     
 1 0.87 0.80, 0.94 0.001 -0.7 -1.1, -0.3 
 ≥2 0.80 0.74, 0.86 <0.001 -1.1 -1.5, -0.8 
GP interdisciplinary 
collaboration (ref. 0) 
 
    
 1 1.76 1.59, 1.96 <0.001 2.8 2.3, 3.3 
 ≥2 2.52 2.32, 2.74 <0.001 4.6 4.2, 5.0 
Out-of-hours home visits 
(ref. 0) 
     
 1 1.04 0.92, 1.17 0.553 0.2 -0.4, 0.8 
 ≥2 1.26 1.03, 1.54 0.024 0.1 0.1, 2.2 
Out-of-hours 
consultations (ref. 0) 
     
 1 0.85 0.77, 0.92 <0.001 -0.8 -1.3, -0.4 
 ≥2 0.78 0.67, 0.90 0.001 -1.3 -2.0, -0.5 
Hospital days 0.95 0.94, 0.95 <0.001 -0.3 -0.3, -0.3 
OR: Odds ratio. GP: General practitioner. OOH: Out-of-hours. Predicted probabilities represent change 
relative to reference category.  
 
The number of GP home visits (1: IRR 1.21, CI 1.16, 1.26 and ≥2: IRR 1.39, CI 1.33, 
1.46), GP office consultations (1: IRR 1.38, CI 1.34, 1.44 and ≥2: IRR 1.63, CI 1.58, 
1.68) and GP interdisciplinary collaborations (1: IRR 1.51, CI 1.45, 1.57 and ≥2: IRR 
1.94, CI 1.88, 2.00) were associated with patients having an OOH contact in a dose-
dependent manner. Having ≥1 GP office consultation or GP interdisciplinary 
collaboration resulted in nearly three more days hospitalized. While one GP home visit 
increased IRR of hospitalization resulting in a one-day increase in days hospitalized, 






5.1 Methodological considerations 
5.1.1 The material 
Research in palliative end of life care has potential ethical challenges related to 
carrying out primary data collection in clinical studies, due to patient and caregiver 
burden, vulnerability of participants, consent and capacity issues.137 Routinely 
collected data can be used to follow patients over time, including utilization of health 
care services, without potentially adding burden.  
This thesis aims to investigate the relationship between health care services, 
sociodemographic factors and dying at home. All three papers used routinely collected 
data. Data was registered prospectively by the registries and collected retrospectively 
by the researchers. Paper 1 had a cross-sectional design, whereas Paper 2 and 3 were 
longitudinal. Data was linked with information from several official registries and 
databases, covering the entire Norwegian population. The Regional Ethical Committee 
granted exemption from confidentiality, and data were collected without consent from 
participants. Steps were taken to ensure confidentiality of study participants, of which 
the most important in this thesis were: 1) No actual dates were used. Date of death was 
set to day zero and all events decremented for each day of the last 90 days of life. 2) 
Age was grouped into intervals of 5-10 years. 3) In Paper 1 and 2, cause of death had 
a lower detail level for younger age groups.  Data used in Paper 1 and 2 were 
anonymous. In Paper 3, they were indirectly identifiable. Information about the 
quality of the linked registries and databases are discussed in Section 3.1. 
An evident strength of using routinely collected data, is that we could include a large 
study sample, covering the entire population of individuals who died over two whole 
years. This has the potential to provide robust population-level measures of the 
utilization of health care services and quality of end of life care; shed light on patterns 
of use of health care services; and be helpful for developing a public health 
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approach.138, 139 We believe we are the first to thoroughly quantify health care service 
utilization at the end of life at a population level in Norway. 
Palliative end of life research has issues related to selection and recruitment of 
participants.137 Selection bias occurs when there are systematic differences between 
subjects included in a study and those who are not included; and further bias can be 
introduced through systematic differences in non-response or attrition by participants 
in a study.137 We largely avoid problems of selection bias, non-response bias and 
attrition bias. Norway’s universal healthcare ensures more equitable access to health 
care services, although differences in access or use of services is a problem. By using 
registry data, which in Norway contains individual-level socioeconomic data, we are 
able to include hard to reach populations, such as individuals who are not identified as 
being in need of palliative care, nearing the end of life, or never receive health care 
services at the end of life.139 Recall bias, a systematic error which occurs because of 
inaccurate or varied recall from study participants,137 is largely avoided when using 
registry data. Missing values are also a minor problem (see Section 3.3). 
Several limitations apply when using registry data in research. Routinely collected 
data is registered prospectively on an individual level, but not necessarily or only for 
research purposes.139 Analyses are limited by what type of information is available. 
We chose measures previously related to dying at home that was available in the 
registries used in the thesis, but other factors may influence the ability to remain at 
home that we did not have access to. In all three papers, we could not account for 
specialized palliative care. The exception was hospital admissions where the main 
reason for admission was palliative care, which in our material was negligible (128 
hospital admissions with ICD-10 diagnosis Z515, 91% cancer-related).  
We could not investigate the quality or appropriateness of health care services 
provided. Patient reported outcomes, including preferences regarding end of life care 
or quality of life, the quality of family relationships, support or caregiver burden are 
unavailable. Instead, we used indicators of whether appropriate care was provided or 
not. Quality indicators for appropriate and inappropriate health care services at the end 
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of life has been developed when using population-based administrative data across 
health care settings, to assess the performance of a health care system relating to end 
of life care.140 Acceptability and validity have been assessed through expert meetings 
and feasibility tested with administrative data.140, 141 Across conditions, quality 
indicators in end of life care include timely receipt of palliative care, hospital 
admissions, emergency department admissions, home death versus hospital death, and 
GP contacts.140    
Another important limitation when using registry data is related to access and linking 
of data. Due to regulations requiring all data involving the IPLOS registry to be 
anonymous, we could not link all the information that we initially planned. Lacking 
information about home nursing services and skilled nursing facility care would be a 
great loss to our study, and a pragmatic solution was to divide it into two substudies. 
This led to substudy 1 linking data from IPLOS and NCoDR (Paper 1 and Paper 2) 
and, substudy 2 linking data from NCoDR, KUHR, NPR, Statistics Norway and the 
Norwegian Prescription Database (Paper 3). The Norwegian Prescription Database 
linked the data for substudy 2, but no prescription data were used in Paper 3.  
A consequence of this division is that we could not make direct inferences about the 
relationship between nursing services (home nursing and skilled nursing facilities) and 
physician led services (GP, OOH, hospital) in relation to the end of life or dying at 
home. In Paper 3 we partly accounted for home nursing services by investigating 
GPs’ interdisciplinary collaboration, which is predominantly with home nursing 
services. Additionally, we accounted for people with long-term skilled nursing facility 
care in regression models in Paper 3, with a prediction model for the probability of 
long-term skilled nursing facility care based on data from substudy 1 (IPLOS and 
NCoDR).  
Accessing data was time consuming. We started the application process in December 
2014 with an application to the Regional Ethical Committee, followed by applications 
to the Data Protection Authority and the individual registries and databases. One year 
later, in December 2015, IPLOS declined our application. Another nine months went 
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by before issues related to data linkage with IPLOS were resolved. Data for substudy 1 
was delivered in March 2017 and data for substudy 2 was delivered in June 2018. It 
took 3.5 years from the application process started until all data were received by the 
researchers. Problems with accessing data have also been reported by other researchers 
as cumbersome, time consuming and costly; in which we agree.142, 143 It is also 
inefficient use of resources and may lead to delay of important research findings.142 
5.1.2 The measures 
Potentially planned home deaths 
Most research on planned home deaths are clinical interventions to try to enable more 
home deaths, studies about congruence between preferred and actual place of death or 
the presence of specialized home palliative care in a population.34, 39, 52, 144-147 These 
studies do not give information about the proportion of dying people who plan to stay 
at home at the end of life. We did not have information about patient or caregiver 
preferences regarding place of care at the end of life or place of death or whether plans 
were made to stay longer at home or die at home. Instead, we used an indirect method 
to estimate the number of potentially planned home deaths. The goal was not to 
estimate peoples’ preferences, but rather differentiate between people whose deaths 
appeared sudden or unplanned from those where health care service utilization implied 
that resources were allocated to facilitate time at home and possibly a home death.  
While estimate 1 (Figure 3, p 34) was based on receiving domiciliary care anytime 
during the last three months, we chose receiving home nursing services within seven 
days before death as the latest time compatible with receiving palliative care at home 
in estimate 2 (Figure 4, p 35). We evaluated how sensitive the estimate was to changes 
in timing of home nursing by replacing seven day with 14 days before death. The 
change resulted in 813 more deaths being classified as potentially planned home 
deaths (1.5% absolute increase). For most people, receipt of home nursing services 
started at an earlier time.  
The decedents with diagnoses most likely to receive palliative care were used in the 
estimates, and probably led to misclassification of some individuals. Cause of death 
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criteria were more inclusive in estimate 1 than in estimate 2. Especially in estimate 1, 
deaths from acute illness may have been classified as potentially planned to occur at 
home. We thus adjusted estimate 2 in Paper 2, to correct for this likely 
misclassification. The two estimates show that potentially planned home deaths that 
occurred at home were rather similar, with 6.3% of all deaths in estimate 1, and 4.3% 
in estimate 2. Still, people dying from other conditions than those included in our 
definition may have had planned home deaths.  
We do not know of anyone else who has estimated number of deaths potentially 
planned to occur at home, which makes comparison with other research difficult. In a 
Canadian study with 1306 informants, 46% of decedents had voiced a preference 
about place of death to their next-of-kin. While 75% preferred to die at home, nearly 
40% actually died at home.146 Similarly, in an English study with 1422 informants, 
36% of family caregivers had knowledge about the deceased person’s preference about 
place of death. Of these, 74% expressed a preference to die at home, while only 13% 
died at home.148 Both these studies show incongruence between preferred and actual 
place of death, but may not be generalizable due to small study populations and design 
with questionnaires/interviews with bereaved relatives. The substantial difference is 
somewhat similar to the difference we found when estimating potentially planned 
home deaths for community-dwelling people and actual home deaths. The results are 
not directly comparable, but may give an indication of how our estimates perform.  
Although our data cannot give information about preferences or plans to stay at home 
at the end of life, we believe our estimates of potentially planned home deaths 
represent a valid indication. Without the support of home nursing services, planned 
home deaths would not be feasible for most people and the presence of this services 
itself signals facilitation of staying longer at home. Our finding that people with 
potentially planned home deaths for the most part had a low probability of having 
short-term skilled nursing facility stays and that 47% followed the trajectory with a 
high level of home nursing services, indicates that time at home and possibly a home 
death was prioritized. However, we cannot exclude that some people died at home 
with help primarily from family caregivers and/or specialized palliative care services. 
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People dying from cancer have a higher probability of receiving specialized palliative 
care.48, 49 Additionally, people with potentially planned home deaths are unlikely to 
have an unknown or sudden underlying cause of death, which we accounted for in our 
estimates. Since palliative care is mostly provided to cancer patients, we believe our 
more inclusive estimates represent an overestimation rather than an underestimation.  
Health care services 
For all measures of health care services, we can account for the presence of a specific 
service from valid sources, but not the specific content or quality of the service.  
Information about home nursing services and skilled nursing facility stays from IPLOS 
is based on municipalities’ report of service decisions including type of service and 
assigned amount of time each week, but not the actual service provided. These 
decisions are based on assessed needs of the recipient and may be interpreted as a 
proxy for the person’s function at the end of life. Although assessments may be more 
valid for activities of daily living than cognitive impairment (see Section 3.1.2), we 
believe this is not critical when assessing home nursing services at the end of life, 
since most people with dementia reside in skilled nursing facilities at the end of life in 
Norway.  
Information about GP and OOH contacts is based on billing claims covering >99% of 
all billing claims. It is considered a reliable information source regarding contacts 
between patients and physicians. We excluded 42 billing claims with errors, out of 
>480,000 billing claims in our data material; too few to have influenced our results. 
The Norwegian Health Economics Administration has strict control of claims and 
variation in fee codes, which leads us to assume high consistency in use of fee codes 
among physicians, including the fee for contact type. It is a strength of our material 
that we could connect patients with their personal GP and thus account for variations 
explained by differences between GPs regarding e.g. home visits to patients. 
It is a major limitation that we could not directly look at interactions between nursing 
services and physician services in primary care, since we were not given permission to 
link these data. We used the fee codes for communication with other municipal 
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professionals regarding the patient (n=32,267) and interdisciplinary meetings (n=697) 
to measure the GPs interdisciplinary collaboration. Although some of these contacts 
probably were with other professionals such as physiotherapists, a majority were with 
home nursing services. Thus, we used this measure as a proxy for interdisciplinary 
collaboration between GPs and home nursing service.  
Cause of death 
Cause of death is a common measure to classify people in palliative end of life 
research using administrative data. Cause of death in NCoDR refers to the underlying 
cause of death, meaning the illness or injury that started the path leading to death, and 
not necessarily the immediate cause of death. Around 50% of underlying causes of 
death are identified automatically, while 50% require manual assessment and 
sometimes additional reporting.113 It is a problem that few causes of death are verified 
by autopsy. However, differences in cause of death determined from death certificate 
and autopsy in autopsy studies are challenging to interpret, due to the highly selected 
population autopsies are performed on. The results are probably not directly 
transferable.113 Use of unspecific codes have lowered the score of NCoDR in quality 
assessments, but is generally assessed as high. Death certificates are similar and 
comparable across countries, making cross-national comparisons more reliable.113  In 
Paper 1 and Paper 2, the age group 0-39 years had a lower detail level for cause of 
death than older age groups. We do not think it has substantially altered our findings 
since we mainly used main chapters in the European Shortlist for Causes of Death.  
Family caregivers 
We did not have any information about whether the decedents had family caregivers or 
the extent of such care. We used household in Paper 1 and 2, and marital status and 
number of children in Paper 3, as proxy measures for the presence of a family 
caregiver. There is a risk of misclassification, because the presence of a family 
member does not give any information about their involvement in end of life care. 
Children may not be living close by, be estranged, not be able or wish to provide care 
at the end of life. A spouse or partner may be a stronger indicator, since elderly people 
are more likely to receive care by their spouse or partner than their children.111 
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However, the spouse or partner may be unable to provide care due to various 
circumstances, such as his/her own functional impairment or by living in a skilled 
nursing facility. Additional risk of misclassification applies to the household variable 
used in Paper 1 and 2, due to 1) IPLOS’ definition of cohabitation (see Section 3.3: 
Covariates); and 2) this variable was only available for the population registered in 
IPLOS. Because of this, results regarding family caregivers should be interpreted with 
caution. 
5.1.3 Statistical methods 
We chose to include Pearson Chi Square tests with p-values for bivariate analyses in 
Paper 1 and 2. However, since we included the whole population of deceased, 
observed differences represent actual differences. In line with this, only proportions 
were presented in Paper 3.  
From regression analyses we show both confidence intervals and p-values to indicate 
the direction of the association and the statistical significance. Some of our measures 
were estimates or proxy measures, which means associations should be interpreted 
with some caution. The large study population yields high precision, which is reflected 
by narrow confidence intervals, and makes it more important to evaluate whether 
results represent meaningful differences. The observational design in this thesis means 
that our findings are associations and cannot be interpreted as causal relationships. 
The cross-sectional design in Paper 1 is useful for investigating associations between 
individual factors and associations with dying at home but is not useful for 
investigating the development of health care services provided.  
In Paper 2 we investigated the development of home nursing services and short-term 
skilled nursing facility stays with a group-based trajectory model. This method 
identifies groups of individuals who follow a similar developmental trajectory of the 
outcome of interest with a maximum likelihood method, in our case, nursing 
services.149 One major advantage of this method, is that we do not have to make any 
prior assumption about groups, which makes it possible to identify trajectories we did 
not anticipate. Each group is conceptually thought of as a collection of individuals 
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following approximately the same developmental trajectory,149 and not based on 
variation around a population mean or application of hierarchies. Furthermore, the 
statistical approach to identifying groups can separate random variation from real 
differences within the population.149 The method also gives probabilities of group 
membership for each individual as a measure of uncertainty. Factors associated with 
specific group membership are considered after model estimation. Model selection is 
based on statistical tests and objective standards, but also clinical judgement about the 
models, which may be considered a limitation. It is a reminder that group-based 
trajectory models represent an approximation of reality.149 
Results in Paper 3 give the impression of a lower proportion of persons receiving GP 
services than the actual proportion. The population at risk of receiving such services is 
lower than the total population, since people in long-term skilled nursing facility care 
are not at risk of receiving GP services (see Section 3.4 Statistical analysis: Paper 3). 
OOH services and hospitals are correctly presented, since these services provide care 
also to long-term skilled nursing facility residents.  
We could not identify people who were in long-term skilled nursing facility care in 
Paper 3. To reduce bias in analyses, we used propensity score covariate adjustments 
for the probability of being in long-term skilled nursing facility care. Propensity score 
covariate adjustment means that the propensity score was used as a predictor to reduce 
confounding in the multivariable logistic regression model with place of death as 
outcome.150 Propensity scores are limited by the quality of the propensity score model. 
In our model, we had a large study sample and the model fit was excellent (see Section 
3.4 Statistical methods: Paper 3). By using propensity score covariate adjustment, we 
reduced bias in our estimates of health care service associations. In retrospect, we 
realize we should have asked for data in this substudy to include community-dwelling 
people only.  
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5.2 Discussion of study results 
Few people die at home in Norway.  The proportion of home deaths is somewhat 
modified with 22% deaths occurring at home when considering only the community-
dwelling population. Although we estimated that almost a quarter of community-
dwelling people may have had potentially planned home deaths, only a minority 
occurred at home. In the following sections I will discuss some of the factors related to 
dying at home in Norway, with a focus on individual factors and health care services 
in relation to dying at home.   
5.2.1 Individual factors 
Sex and age 
Studies from other countries are varying in the relationship between home death, sex 
and age.7, 15, 35, 38, 151 Although more women died in our study, a larger proportion of 
men died at home. In adjusted analysis the results regarding sex were conflicting. 
Predicted probabilities were small, with men having a 2.1-2.4% higher predicted 
probability of dying at home in Paper 1 and 2, but 3.6% lower in Paper 3. For deaths 
outside the home, women died more often in skilled nursing facilities and men more 
often in hospitals, similar to findings in a Swedish study.8 The difference between the 
sexes may be linked to that women traditionally provide care to a spouse at home and 
that women die at an older age. Variations we found related to sex are small in 
adjusted analyses, and is probably in itself not a key factor for staying at home at the 
end of life.  
Absolute number of home deaths were higher for the older age groups, but a higher 
proportion died at home within younger age groups. Altogether, 26.5% of people <70 
years died at home, but only 11.8% ≥70 years. In adjusted analysis there was a clear 
age trend where younger age was associated with dying at home in both the total 
population and among community-dwelling people. Among the community-dwelling, 
people aged 40-49 years had the highest odds of dying at home compared to hospital. 
In Paper 1, potentially planned home deaths were associated with increasing age but 
decreased from 70 years in a subgroup controlling for cohabitation. A Norwegian 
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study found that changes in place of death with less hospital and home deaths and 
accordingly more skilled nursing facility deaths, could largely be explained by 
changes in the population of decedents, with people dying at an older age, women 
living longer than men, and a shift to more people dying from chronic debilitating 
conditions.4 Place of death may also be influenced by differences in access to and 
quality of health care services at the end of life for different age groups. Adsersen et 
al. found that older Danish cancer patients were less likely to be admitted to 
specialized palliative care,152 while Lindskog et al. found that older age was associated 
with a risk of poor end of life care quality for Swedish cancer patients.153 Another 
study compared palliative care in Spain, Italy and Belgium, and found that the quality 
of general palliative care could be improved for older age groups.154  
Cause of death 
Circulatory disease and cancer are the most frequent causes of death in Norway and 
were also most frequent causes of death at home in this thesis. Several studies have 
compared end of life and palliative care for cancer patients and other patient groups. 
The findings are highly consistent across all studies, in pointing out the inequalities 
between cancer patients and other patient groups in both recognition of needs, and 
access to appropriate care at the end of life.52, 53, 56, 76, 155-157  
We found that people with cancer had lower relative risk ratio of dying at home in 
adjusted analyses compared to circulatory disease. Only 12% died at home and >70% 
died outside their permanent residence (38% hospital, 35% short-term skilled nursing 
facility). Despite this, a larger proportion of people dying from cancer (within 
diagnosis group) had potentially planned home deaths, both regardless of actual 
location of death and which occurred at home. Almost 60% of people dying from 
cancer received home nursing services, and they constituted the largest diagnosis 
group in all the trajectories receiving home nursing services. A larger proportion of 
cancer patients received GP home visits and had the GP involved in interdisciplinary 
collaboration. They also had less OOH contacts, but the most hospitalizations.  
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Our findings support previous findings that people dying from cancer receive more 
‘appropriate’ health care services at the end of life. At the same time, they spend more 
time hospitalized and rarely die at home. This phenomenon of more ‘appropriate’ end 
of life care not necessarily leading to doing less of other things or more time spent at 
home, has been showed previously.158  
Dementia is in the top-five list of causes of death in Norway.159 Only 0.3% of all 
deaths were caused by dementia and occurred at home, while almost 1% had dementia 
mentioned on the death certificate and died at home. As expected, the vast majority 
died in long-term skilled nursing facilities. Although approximately 80% of people in 
long-term skilled nursing facilities have dementia,160 only 17% of long-term skilled 
nursing facility deaths in our material were categorized as caused by dementia, while 
32% had dementia mentioned on the death certificate. This suggests that dementia is 
under-reported as cause or contributing cause of death. Our findings may also reflect 
that dementia is a progressive disease with early, prolonged and severe functional 
decline,59, 161 which makes it harder to stay at home towards the end of life, and may 
not be feasible for the majority of persons living with dementia. A recent Belgian 
study found that community-dwelling people with dementia received less palliative 
care than cancer patients, and changes over time in use and timing of palliative care 
were lower among this group than other groups dying of conditions indicative of 
palliative care.162 One reason may be perceived difficulty in recognizing the end of 
life, but also in acknowledging dementia as a terminal illness. 
Another important finding is that it appears people are more likely to die unplanned at 
home from conditions that are more often a result of acute illness, such as an acute 
cardiovascular event, ill-defined or external causes. In adjusted analyses in Paper 1, 
people with ill-defined or external causes of death had a higher relative risk ratio of 
dying at home. Furthermore, people who died at home were more often men, lived 
alone or were without a family (partner and/or children). All registered deaths at home 
from ill-defined or external causes were men in our material, and men also died more 
often at home from circulatory disease. These findings are not surprising with a very 
low number of total home deaths. Findings from other studies support our findings, 
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and suggest that a large proportion of sudden unexpected deaths (a majority cardiac 
deaths) occur at home, more often among men, and a majority among older 
patients.163-165 
Overall, cancer patients appear to receive the most ‘appropriate’ end of life care in 
primary health care, as well as specialized palliative care, but are unlikely to die at 
home. Frail people dying from dementia are especially disadvantaged in staying at 
home and mostly die in long-term skilled nursing facility care. A large proportion of 
home deaths appear to be sudden unexpected deaths. Our findings warrant more focus 
on clarifying the goals of the patient and caregivers at the end of life. There are many 
missed opportunities to identify and provide palliative care to enable people to stay 
longer at home; especially among non-cancer patients. 
Family caregivers 
Previous studies have shown that having a family caregiver is very important to be 
able to die at home.34 In Norway, elderly people receive more help from their spouse 
than their children.111 Those who have a spouse or child receive less municipal health 
care services, especially when the spouse or child is female, and imply that family 
caregivers substitute official health care services.166 While family caregivers are 
important for staying at home at the end of life, and provide a substantial amount of 
care,111 changing family structures may be contributing to declining home death rates. 
Norway has a high employment rate, also for women,167 who traditionally provide 
such care. Divorce and breakups are common,168 and birth rates are declining.169 All 
these factors may contribute to lower availability of care provided by the family.   
Our results about family caregivers should be interpreted with caution due to 
limitations discussed in Section 5.1.2 and small differences between groups. We found 
that dying at home was associated with living alone, being unmarried and without 
children. Potentially planned home deaths were associated with living with someone. 
These findings fit well with a high proportion of sudden and unexpected deaths 
occurring at home. Family caregiver burden may be high.170-173 Uncertainty about what 
to expect due to lack of planning and inadequate support from the health care 
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system,171 in addition to limited time to provide care, may result in having their loved 
one moved to an institution feeling safer than staying at home. This may partly explain 
our finding with increasing probability of being admitted to a short-term skilled 
nursing facility towards the end of life, and that over a third of the population was 
hospitalized in the last week of life.  
A Norwegian qualitative study found that older community-dwelling cancer patients 
and their family experienced that health care services were not tailored to their needs 
in the palliative phase,174 and may clarify why many do not remain at home at the end 
of life. They experienced exhausting cancer follow-up in hospitals, where especially 
travels between the home and hospital led to patients discontinuing follow-up. Many 
frail patients had trouble visiting their GP’s office since many GPs did not offer home 
visits, and some had low confidence in the GPs competency. Additionally, the 
patient’s family felt they were not involved, received little information and 
experienced that care was fragmented with little continuity of care from hospital, home 
nurses, and the GPs.174 Continuity of care is important to ensure that the patients and 
families feel safe at home.175  
5.2.2 Health care services 
Home nursing services 
A quarter of the community-dwelling population received a high amount of home 
nursing services, almost 7 hrs/wk, of which half had potentially planned home deaths. 
Only the high home nursing trajectory was associated with dying at home in adjusted 
analyses. Our results complement findings that specialized palliative home nursing or 
multidisciplinary teams increase the likelihood of dying at home,34, 39, 176, 177 by 
showing that also regular home nursing of a certain intensity and continuity was 
associated with an increase the likelihood of dying at home. The absolute increase in 
predicted probability for dying at home was small (3.5%) compared to receiving no 
home nursing services. Still, continuity of care may have contributed to some patients 
and their families feeling safe at home,41 and have given home nurses confidence in 
assessing and treating distressing symptoms because they knew the patient and family.  
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Webber et al. showed that implementation of a home-death planning tool (advance 
care planning) and a home medication kit in publicly funded home nursing services 
increased the likelihood of dying in the community.178 There were also indications of a 
reduction in hospitalization in the last six month before death.178 Norwegian home 
nurses also reported that use of a medication kit and planning together with the 
patients GP increased confidence in providing end of life care at home.179 Another 
recent qualitative study from Norway found that both home nurses and GPs 
experienced in providing palliative care, underlined collaboration between the patient, 
family, primary and secondary health care for palliative care at home to be effective.180 
Especially, a good start and safe discharge routines from hospital were emphasized.180  
Receiving <1 hour per day of home nursing at the end of life is little when we know 
that most dying people have substantial functional decline towards the end of life.59, 60, 
62, 161 It is thus not surprising that e.g. the accelerating home nursing trajectory, starting 
closer to death and amounting to <2 hrs/wk of home nursing was insufficient to stay at 
home, even if more time at home may have been a priority.  People following this 
trajectory were more likely to die in a short-term skilled nursing facility.  
Almost 9% of the community-dwelling population had decreasing home nursing and a 
low probability of being admitted to short-term skilled nursing facility care. This could 
represent a situation where family caregivers took responsibility for end of life care at 
home. Other likely scenarios are that death was sudden, unexpected or that they were 
followed by secondary health care services. Nearly 60% in this group died in a 
hospital, and 80% had a cause of death indicative of palliative care needs.6  
We found that just over half of community-dwelling people received home nursing 
services at the end of life and 70% had a low probability of being admitted to short-
term skilled nursing facility care. More than half of those who receive home nursing 
are living alone,24 and it may not be feasible to stay at home at the end of life even if 
professional support is provided. For some, a transition to a skilled nursing facility or 
hospital may be appropriate due to lack of symptom control, or high caregiver burden 
or absence of a family caregiver. Although we do not know the preferences of the 
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decedents, our findings point to a need for more advance care planning and that more 
people could benefit from receiving general palliative care from home nursing 
services. For this to be successful, increased knowledge, skills and experience in 
caring for dying patients, along with time, available equipment and tools is needed. 
General practitioners 
Previous studies have shown that GPs are important in providing general palliative 
care at home by offering continuity of care, by performing home visits and 
collaborating with other health care professionals, especially for cancer patients.73, 81, 
85, 86, 140 A study in four European countries found that GPs were aware of their 
patients’ preferences regarding place of death in <50% of cases when the patient died 
non-suddenly from cancer; a majority preferred to die at home. Those who had a 
known preference and received palliative care from their GP had greater chance of 
dying at home.31 Our findings confirm that follow-up from GPs at the end of life in 
form of home visits and interdisciplinary collaboration is associated with more home 
deaths. Both factors increased the probability of dying at home in a dose-dependent 
manner, but the absolute effects were small for each component (Table 5, p 49).  
Together with the high home nursing trajectory, GP home visits and interdisciplinary 
collaboration constituted the three types of health care services positively associated 
with dying at home in Norway. Almost a quarter of community-dwelling people 
received such home nursing services (the population at risk). In total, 12% of the 
population received home visit(s) and interdisciplinary collaboration in combination in 
the final three months of life. This corresponds to 18% of the community-dwelling 
population. Only 7% of patients received both home visit(s) and had a GP 
collaborating with other healthcare professionals in the last four weeks of life, 
corresponding to 10% of the community-dwelling population. A Norwegian report 
found that many patients are satisfied with their GP, but few patients who reported a 
need for GP home visits received it.181 One reason for not providing palliative end of 
life care is probably lack of timely recognition of palliative care needs or not 
anticipating that the end of life is close, and not going through the process of advance 
care planning.67-69, 182-185 
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In 2012 the Coordination reform was implemented in Norway with a goal to improve 
coordination and collaboration between primary and secondary healthcare due to 
fragmented health care services and increasing costs.20 Responsibilities and tasks were 
transferred from secondary to primary health care to achieve a goal of patients getting 
health care services closer to home, reduce hospitalizations, relieve pressure on 
secondary health care services and lead to cost reductions.20 As a consequence 
municipalities and GPs are now responsible for taking care of more patients with 
chronic illness, but also older, frail and multimorbid patients.186 The reform has been 
successful in reducing hospitalization length, but has also led to more 
rehospitalizations.187 It is unknown if patient pathways have improved and become 
more cohesive.187  
In a recent Norwegian qualitative study investigating GPs’ collaboration with 
municipal health care providers, GPs presented prioritization due to limited time as a 
main reason for lack of collaboration, while collaboration partners described large 
individual differences in GPs’ willingness to collaborate.188  Organizational 
differences between GPs and collaboration partners and bureaucratic routines was 
reported to hamper collaboration. There were also examples of GPs being left out in 
collaboration between primary and secondary health care services.188 Excluding GPs 
in collaboration across health care levels and variable collaboration within primary 
health care has been reported by others as well, and may reduce patient safety.180, 189 
Many patients, their families and health care professionals regard GPs as central in 
providing palliative care.75 There is a need for increased competency, better 
interprofessional collaboration and coordination through a better framework in 
provision of palliative care to community-dwelling patients.75 However, evidence from 
a systematic review suggests that strategies for enhancing collaborative working in 
palliative care is often a result of informal interactions rather than systematic 
processes.190 
Recommendations that primary health care physician full time equivalents should be 
increased by 50% to meet requirements that came with the Coordination reform has 
not been followed up.186 GPs have been little involved in development of agreements 
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between primary and secondary health care that became mandatory with the reform, 
but has experienced a significant increase in workload; especially work without direct 
patient contact.186, 187, 191 This may explain an ongoing recruitment and retainment 
crisis in in Norwegian general practice today.192 It may be challenging to add to the 
workload of GPs with a demand of more involvement in palliative end of life care 
without addressing responsibilities and organizational factors first. 
Out-of-hours services and hospital 
We found that GP office consultations were associated with reduced probability of 
dying at home, but the absolute effect was small (1 consultation: -0.7%, ≥2 
consultations -1.1%). It goes well together with other health care services that bring 
the patient out of their own home: OOH office consultations, hospitalizations and 
skilled nursing facility stays, which all reduced the probability of dying at home. 
Furthermore, both GP consultations and GP interdisciplinary collaboration was 
associated with a three day increase in days hospitalized and increased the probability 
of having an OOH contact at the end of life. Most decedents, however, did not have 
any OOH contacts. Hospitalizations on the other hand, escalated towards the end of 
life, especially in the last week before death with more than a third of all admitted to a 
hospital. Interestingly, while one GP home visit was associated with one more day 
hospitalized, ≥2 GP home visits was not associated with more hospitalization; and 
could be an example of better resource use on a population level.193 We do not know 
how many of the hospitalizations were appropriate, but hospitalization at the end of 
life is considered an indicator of inappropriate end of life care.140  
Our findings are similar to results from other European countries, which have also 
found that when the GP had knowledge of the patient’s preferred place of death, the 
probability of being hospitalized was lower.194 However, an increased or large number 
of GP contacts in the last weeks of life has been associated with a reduced likelihood 
of dying at home and higher likelihood of hospitalization and hospital death.31, 83 One 
interpretation is that greater symptom burden and needs required a higher level of 
health care services. Another explanation may be that primary health care services are 
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mainly reactive rather than proactive due to a lack of planning and anticipation of 
needs.  
In a Danish study, GPs reported they often or always offered end of life care to 85% of 
cancer patients and 34-40% of patients with non-malignant disease.94 An Australian 
study found that up to a quarter of GPs did not involve themselves in palliative care at 
all.87 Altogether, around 60-80% of deaths are non-sudden, as judged by physicians 
retrospectively after death.195-198 These findings point to that more deaths could have 
been anticipated and the patient been offered advance care planning and general 
palliative care, initiated by a more proactive GP. Reasons for not delivering palliative 
care include lack of knowledge, skills or confidence in providing palliative care (both 
symptoms and psychosocial aspects), not recognizing palliative care needs of patients, 
bureaucratic procedures, difficult communication between healthcare professionals, 
lack of continuity and collaboration between services, continuity OOH, limited 
resources and time, having other commitments, and sometimes lack of interest.87, 88, 199  
End of life care may be organized to reduce hospitalizations at the end of life by 
improving communication about care preferences and having a more involved GP who 
has knowledge about end of life care.194 Previous studies have found that the GP is 
involved in only 25-46% of hospitalizations of their patients, with patients and/or 
families, OOH services, outpatient clinics or agreements directly with hospital wards 
being responsible for the rest.32, 200, 201 This may be due to other health care services 
not involving the GP in decisions about hospitalization, but also lack of involvement 







This thesis has investigated home deaths in Norway in relation to health care service 
utilization at the end of life and differences in personal characteristics of decedents.  
We found that few people died at home in 2012-2013. A majority of deaths appears to 
have been unplanned to occur at home, including home deaths.   
The most common causes of death at home were circulatory disease and cancer. More 
men than women died at home. Dying at home was associated with persons who were 
younger, unmarried/living alone, and without children. People dying at home had a 
higher probability of living in municipalities with fewer inhabitants from causes death 
more likely to be sudden and unexpected (external, ill-defined or circulatory disease). 
A larger proportion of persons dying from cancer were estimated to have potentially 
planned home deaths than those dying from other conditions. 
Dying at home was associated with receiving a high number of home nursing hours 
per week in the last three months of life, receiving home visits from GPs and 
interdisciplinary collaboration. Few people received such services, indicating that few 
received appropriate primary health care services at home at the end of life. Health 
care services that required the patient to leave their own home, such as GP office 
consultations, short-term skilled nursing facility stays, OOH office consultations and 
hospitalizations reduced the likelihood of dying at home.  
GP contacts increased the probability of patients having an OOH contact, but few 
people had OOH contacts. Hospitalizations escalated towards the end of life. All GP 
contacts except ≥2 GP home visits were associated with more days hospitalized. 
Our results indicate inequities at the end of life when investigating both individual 
factors and use of health care services. GPs and home nurses may enable more time at 
home or home deaths for people who have this preference. The potential for delivering 





7. Implications and future perspectives 
At a population level, follow-up from GPs and home nursing services at the end of life 
may enable people to die at home. Our results imply that most people dying in Norway 
do not receive enough appropriate follow-up to make a home death feasible. Primary 
health care is under strain. With increasing workload, limited resources and time it 
may not be surprising that home deaths continue to decline. According to official 
palliative end of life care guidelines, care that enables people to die in their preferred 
location should be faciliteted.202 Although we do not know how many people prefer to 
die at home in Norway, it is likely that many people do not have their preferences met.  
Specialized palliative care is a crucial part of our health care system, but it is unlikely 
that they will be able to provide care to all people with life-threatening illness and 
palliative care needs. Specialized palliative care should be delivered to those with 
complex needs and offer support to general palliative care providers. With the right 
resources, general palliative care can be offered by GPs and home nursing services to 
more patients who are approaching the end of life.193 They are in a good position to do 
so. Many people have a long-standing relationship with their GP, and some receive 
home nursing for an extended period. This continuity may be of great value when 
patients approach the end of life. It may also be possible to provide palliative care to 
most patients who are in need, regardless of diagnosis, age, sex or socioeconomic 
status. The potential for palliative end of life care at home from primary health care is 
currently not utilized. 
Death is an inevitable part of life. The question is whether we should accept that dying 
is institutionalized. If not, a good place to start would be to start talking about death 
and dying and about our preferences with the people we care about and who care about 
us. This should preferably also include key health care workers, such as a personal GP.  
Although the focus of this thesis was on dying at home/place of death, which is easier 
to measure on a population level than e.g. time spent in a preferred location, a patient 
centered goal such as days spent at home or in another preferred location may be a 
more appropriate and realistic goal.158 The way forward must include both an 
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individual and a system perspective to give dying people a real choice about where 
they spend the end of life. Health care services should be flexible and tailored to the 
patients’ and family’s needs, which will require more focus on advance care planning 
and systematic ways to identify people who may benefit from palliative care. We also 
need a population-based strategy for provision of palliative care end of life care for 
community-dwelling people, taking current and estimated future needs into 
account.203, 204 This strategy will have to focus on inadequate policies, shortage of 
resources, inequity in access to palliative end of life care, lack of guidelines for people 
not dying from cancer and insufficient education in palliative care.71, 204 Furthermore, 
we need organizational changes in our health care system that facilitate collaboration 
both within primary health care and across health care levels.  
Future studies should focus on improving identification of people in need of palliative 
care, implementation of advance care planning and strategies to improve access to 
palliative care in primary health care. Strategies for implementation and national 
quality indicators to measure the quality of palliative end of life care at a population 







Paper 1:  
In the Method Section, the listed causes of death read: 
These were according to the EU Shortlist: ‘Cancer’ (2.), ‘Heart disease’ 
(7.1.2/7.1, 7.2.2, 7.4), ‘Chronic pulmonary disease’ (8.3.2), ‘Kidney disease’ 
(12.1) and ‘Neurological disease’ (6.1, 6.3).  
The correct causes of death used should read:  
These were according to the EU Shortlist: ‘Cancer’ (2.), ‘Circulatory disease’ 
(7.), ‘Respiratory disease’ (8.), ‘Kidney disease’ (12.1) and ‘Neurological 
disease’ (6.1, 6.3). 
Accordingly, in Figure 1, “Heart disease” should be “Circulatory disease” and 
“Chronic pulmonary disease” should be “Respiratory disease”. 
We notified BMC Palliative Care about this error and if they would publish this 
information as an erratum on two occasions but did not receive a reply. 
Paper 2: 
Figure 1 has “Long-term care (n=24,986)” but should read “Long-term care 
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Comparing unplanned and potentially
planned home deaths: a population-based
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Abstract
Background: There is little research on number of planned home deaths. We need information about factors associated
with home deaths, but also differences between planned and unplanned home deaths to improve end-of-life-care at
home and make home deaths a feasible alternative. Our aim was to investigate factors associated with home deaths,
estimate number of potentially planned home deaths, and differences in individual characteristics between people with
and without a potentially planned home death.
Methods: A cross-sectional study of all decedents in Norway in 2012 and 2013, using data from the Norwegian Cause of
Death Registry and National registry for statistics on municipal health and care services. We defined planned home death
by an indirect algorithm-based method using domiciliary care and diagnosis. We used logistic regressions models to
evaluate factors associated with home death compared with nursing home and hospital; and to compare unplanned
home deaths and potentially planned home deaths.
Results: Among 80,908 deaths, 12,156 (15.0%) were home deaths. A home death was most frequent in ‘Circulatory
diseases’ and ‘Cancer’, and associated with male sex, younger age, receiving domiciliary care and living alone. Only 2.3%
of home deaths were from ‘Dementia’. In total, 41.9% of home deaths and 6.3% of all deaths were potentially planned
home deaths. Potentially planned home deaths were associated with higher age, but declined in ages above 80 years for
people who had municipal care. Living together with someone was associated with more potentially planned home
deaths for people with municipal care.
Conclusion: There are few home deaths in Norway. Our estimations indicate that even fewer people than anticipated
have a potentially planned home death.
Keywords: Home death, Place of death, Death/epidemiology, Death/statistics and numerical data, Death/classification,
Cross-sectional studies, Cause of death, Terminal care, Registries, Retrospective studies
Introduction
Most people wish to spend their last days of life in their
own home and die at home [1]. Despite this, the propor-
tion of home deaths in Western countries continues to
decline [2]. Exceptions include Canada, the UK and the
US, where home deaths have increased the last 15 to
25 years due to implementation of end-of-life programs
and policy changes [2–4]. Home deaths increased from
19.3% in 1994 to 29.5% in 2004 in Canada; from 18.3%
in 2004 to 20.8% in 2010 in the UK; and from 30.7% in
2000 to 33.5% in 2009 in Medicare beneficiaries aged
66 years and older in the US [2–4].
In Norway, home deaths have been declining, with
only 14.3% of deaths taking place at home in 2015 [5, 6].
This is low compared with many other Western
countries [7–16]. While home death is not desirable or
possible for everyone, we need to know more about who
dies at home and influencing factors in order to meet
people’s preference of dying at home, as well as inform
and improve policies. While we know the total number
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of home deaths, this does not describe the proportion of
people who wished to die at home or the number of
deaths that were planned or facilitated to take place at
home. We cannot use registry data to estimate people’s
preferences, but we can differentiate sudden, unplanned
home deaths from home deaths where health and care
service utilisation implies that resources were allocated
to facilitate a home death.
In this study, our aim was first to describe factors as-
sociated with home deaths in Norway, and compare
them with deaths in other locations. Secondly, we aimed
to estimate how many home deaths may have been
planned. Lastly, we wanted to analyse differences in indi-
vidual characteristics between people where home
deaths may have been planned, and people where home
death did not appear to have been planned.
Method
Data source
We linked data from the Norwegian Cause of Death
Registry (NCoDR) and National registry for statistics
on municipal health and care services (IPLOS) cover-
ing all 83,434 deaths in Norway in 2012 and 2013.
Individuals with missing information about place of
death or sex (n = 2526) were excluded. The final study
sample comprised 80,908 individuals.
Information on causes and place of death are registered
in NCoDR [17]. In Norway, the doctor who examines the
dead body completes the death certificate. This could be
the treating general practitioner or institutional doctor,
but also a doctor on night duty. The document is sent to
the local county court/police, then to the Chief Municipal
Medical Officer, before reaching NCoDR. The registry en-
compasses all residents, irrespective of whether they die in
Norway or abroad, and since 2012 also information on
deaths for non-residents. NCoDR has a high degree of
coverage and completeness, with medical information on
more than 98% of all deaths. Three quality assessments
have ranked NCoDR in the second best group with
“medium” and “medium-high” quality respectively, and
lastly in the best group regarding quality. In all these three
studies, the extensive use of unspecific codes served to
lower the score. Few validation studies have been
conducted [17].
IPLOS is a national registry for statistics on municipal
health and care services. Since 2007 it has been the main
data source for Norwegian municipal health and care
statistics. It is compulsory for municipalities to register
information on all persons who apply for or receive mu-
nicipal health and care services, describing the person’s
resources, need of assistance and services provided. Hos-
pital admissions are also registered, but not used here
due to poor data quality. Updates are continuously regis-
tered, and sent to the register annually. Data quality is
assessed by comparison with information in other offi-
cial statistics (KOSTRA – Municipality-State-Reporting)
and reports returned to the municipalities [18, 19].
Outcome measures
NCoDR provided information regarding cause of death,
place of death, age, sex and place of residence (munici-
pality population and centrality). IPLOS provided
information regarding municipal services and household.
We divided place of death into four categories: home;
nursing home; hospital; other (abroad, under transporta-
tion to hospital, other). Cause of death was given by the
European Shortlist for Causes of Death (EU Shortlist)
[20]. Persons missing cause of death, with diagnoses
removed due to privacy or with cause of death main
diagnosis groups with a frequency of less than 5% of all
deaths were labelled “other”. We grouped cause of death
into eight categories: ‘Infectious/parasitic’; ‘Symptoms/
signs/ill-defined’; ‘External’; ‘Cancer’ (including uncertain
malignancy potential); ‘Dementia’; ‘Circulatory’; ‘Res-
piratory’; ‘Other’. Age at time of death was divided into
seven groups (0–39, 40–49, 50–59, 60–69, 70–79, 80–
89, 90+ years). Municipality centrality was defined as a
municipality’s geographic location in relation to a centre
with important central functions, where 0 is least central
(rural) and 3 is most central (urban) [21]. Domiciliary
care was coded ‘yes’ if an individual received practical
help or home nursing at any time 0–90 days before
death. Nursing home was coded ‘yes’ if an individual had
a stay of any duration in a nursing home or rehabilita-
tion facility 0–90 days before death. Individuals residing
in assisted living accommodations with separate
apartments were coded as living alone by IPLOS, while
individuals in long-term institutional care were coded as
cohabiting [18].
Planned and unplanned home deaths
We created an algorithm to estimate potentially planned
and unplanned home deaths (Fig. 1). A home death was
defined as unplanned if a person did not receive domi-
ciliary care during the last ninety days before death or if
a person who died at home with domiciliary care had
cause of death ‘Symptoms/signs/ill-defined’. ‘Symptoms/
signs/ill-defined’ were labelled unplanned, since people
who have a planned home death would most likely have
a known diagnosis of life-threatening disease later
appearing as underlying cause of death in the death cer-
tificate; as opposed to people dying at home suddenly,
but not unexpectedly of an unspecific cause. We defined
a home death as potentially planned if a person had
domiciliary care and a cause of death among the most
likely diagnoses to receive palliative care. These were ac-
cording to the EU Shortlist: ‘Cancer’ (2.), ‘Heart disease’
(7.1.2/7.1, 7.2.2, 7.4), ‘Chronic pulmonary disease’ (8.3.2),
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‘Kidney disease’ (12.1) and ‘Neurological disease’ (6.1, 6.
3) [20, 22]. Because the majority of people with demen-
tia die in nursing homes, cause of death from ‘Dementia’
was not included [23]. The remaining home deaths were
categorised as unplanned. The age group 0–39 years was
given a lower detail level for cause of death than older
age groups due to privacy. Cause of death was divided
into six categories according to diagnoses most likely to
receive palliative care: ‘Cancer’; ‘Circulatory’; ‘Respira-
tory’; ‘Kidney’; ‘Neurological’; ‘Other’.
Analyses
We used frequency tables and Pearson Chi-square for
comparisons. Multinomial logistic regression was used
to compare death at home, in nursing home and hos-
pital. Independent variables were sex, age, cause of
death, municipality centrality, municipality population
and domiciliary care. We did a similar analysis includ-
ing type of household as explanatory variable in a sub-
population of people who received municipal care at
any time (registered in IPLOS). Results are presented
as adjusted relative risk ratios (RRRs) with 95% confi-
dence intervals (CI) and p-values. xWe used logistic
regression to compare potentially planned and un-
planned home deaths. Independent variables were sex,
age, municipality population, municipality centrality
and nursing home stay (model 1). We did a separate
analysis for people who received municipal care at any
time (registered in IPLOS) with household as an ex-
planatory variable (model 2). Unadjusted and adjusted
odds ratios (ORs) with 95% CI and p-values are pre-
sented. Significance was accepted at the 5% level (p <
0.05) for all analyses. Analyses were conducted with
STATA 14 (Stata Corp, College Station, TX).
Fig. 1 Algorithm for potentially planned and unplanned home deaths
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Results
Describing the population
Among 80,908 deaths 12,156 (15.0%) were classified as
home deaths. In total, more women died, with the ma-
jority (56.5%) dying in nursing homes (Table 1). While
18.1% of all men died at home, only 12.2% of all women
died at home.
Absolute number of home deaths was higher in the
older age groups. However, within each age group, home
death was more frequent for younger persons (Fig. 2). In
people 0–69 years, 26.5% died at home, 19.7% in a nursing
home, 44.6% in a hospital and 9.2% in other locations.
Only 11.8% of people 70 years or older died at home,
while 56.8% died in a nursing home, 30.1% in a hospital
and 1.3% in other locations. The most common causes of
death were ‘Circulatory diseases’, ‘Cancer’, ‘Respiratory dis-
eases’, ‘Infectious diseases’ and ‘Dementia’ (Table 1). ‘Circu-
latory diseases’ (34.9%) and ‘Cancer’ (21.8%) were also the
most frequent causes of death within the home death
group, while only 2.3% were from ‘Dementia’.
A large proportion of deaths had missing information
regarding household, largely reflecting people who never
received municipal care (Table 1). For those who had
services at any time, people living alone (14.2%) died at
home more often than those living with others (9.5%). In
total, 11.6% had a nursing home stay and 58.0% received
domiciliary care in the last 90 days before dying at
home. Of all persons who had a nursing home stay in
the last 90 days before death, 3.0% died at home, while
17.9% of those receiving domiciliary care died at home.
Comparing home deaths with deaths in nursing homes
and hospitals
Multinomial regression showed that women had a lower
relative risk than men for dying at home compared with
nursing home (Table 2). We found an age gradient with
more home deaths in younger age groups, except for
people aged 90 years or older who had a higher relative
risk for dying at home than in a hospital, but highest
relative risk of dying in a nursing home. People who died
from ‘Cancer’ and ‘Respiratory disease’ had lower relative
risk of home death than ‘Circulatory disease’ compared
with nursing home and hospital. People with ‘Dementia’
had higher relative risk of dying in nursing homes than
home, but lower relative risk of dying in hospitals. Re-
cipients of domiciliary care had higher relative risk of
dying at home than in nursing homes or hospitals. A
similar regression analysis with only persons who at any
time had received municipal care (registered in IPLOS),
including household as independent variable, did not
alter main findings, but showed that people living with
others had lower relative risk of home death compared
with death in nursing home (RRR 0.77, 95% CI 0.73, 0.
82) and hospital (RRR 0.90, 95% CI 0.87, 0.94).
Comparing potentially planned and unplanned home
deaths
According to our algorithm for estimating potentially
planned and unplanned home deaths (Fig. 1), 56.1% of
home deaths and 8.4% of all deaths were potentially
planned home deaths when we included everyone with
domiciliary care but not ‘Symptoms/signs/ill-defined’
causes of death. In the full algorithm, including cause of
death, 41.9% of home deaths and 6.3% of all deaths were
potentially planned home deaths. Men had a higher pro-
portion of both potentially planned and unplanned
home deaths than women (Table 3). In people aged
50 years or older 44.5% of home deaths were potentially
planned, but only 15.7% in those younger than 50 years.
Living alone was more frequent in both potentially
planned and unplanned home deaths, but more than half
of unplanned home deaths had missing information re-
garding household, making comparisons uncertain.
While 84.0% of ‘Cancer’ home deaths were potentially
planned, this constituted only 10.2% of all ‘Cancer’
deaths. The proportion of potentially planned home
deaths among all home deaths and total number of
deaths for each diagnosis were 76.4% and 8.5% in
‘Neurological disease’, 69.2% and 7.4% in ‘Renal disease’,
63.2% and 7.3% in ‘Respiratory disease’ and 48.8% and 8.
3% in ‘Circulatory disease’, respectively. Moreover, 72.1%
of all home deaths and 12.9% of all deaths were poten-
tially planned in recipients of domiciliary care.
Table 4 compares two regression models of poten-
tially planned versus unplanned home deaths. In
model 1, including all home deaths, women had
higher odds than men for having a potentially
planned home death, but in model 2, which was
restricted to include people who at any time had
received municipal care, women had lower odds for
having a potentially planned home death. Higher age
was associated with more potentially planned home
deaths, but in model 2 ages 60–79 years had the
highest odds, with declining odds in older age groups.
Municipalities with less than 50,000 inhabitants were
consistently associated with more potentially planned
home deaths, of which municipalities with 5001–
10,000 inhabitants had the highest odds. A nursing
home stay during the last 90 days before death was
associated with higher odds for a potentially planned
home death in model 1, but had lower odds in model
2. Living together with someone increased the odds
for a potentially planned home death in model 2.
Discussion
Main findings
This population-based registry study showed that
home death in Norway was most frequent in ‘Circula-
tory disease’ and ‘Cancer’, and associated with male
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Table 1 Distribution of sociodemographic factors and municipal healthcare services by place of death in Norway 2012–2013.*
Place of death
Home Nursing home Hospital Othera Total
n % n % n % n % n %
All 12,156 100 39,345 100 26,962 100 2445 100 80,908 100
Sex
Female 5175 42.6 23,904 60.8 12,613 46.8 598 24.5 42,290 52.3
Male 6981 57.4 15,441 39.2 14,349 53.2 1847 75.5 38,618 47.7
Age (years)
0–39 549 4.5 70 0.2 796 3.0 426 17.4 1841 2.3
40–49 550 4.5 191 0.5 724 2.7 263 10.8 1728 2.1
50–59 1249 10.3 776 2.0 1877 7.0 389 15.9 4291 5.3
60–69 2381 19.6 2477 6.3 4553 16.9 564 23.1 9975 12.3
70–79 2538 20.9 5917 15.0 6212 23.0 386 15.8 15,053 18.6
80–89 3293 27.1 16,595 42.2 9134 33.9 338 13.8 29,360 36.3
90+ 1596 13.1 13,319 33.9 3666 13.6 79 3.2 18,660 23.1
Cause of death
Infectious/parasitic 1077 8.9 3562 9.1 2131 7.9 264 10.8 7034 8.7
Cancer 2648 21.8 10,728 27.3 8431 31.3 106 4.3 21,913 27.1
Dementia 274 2.3 4951 12.6 211 0.8 11 0.5 5447 6.7
Circulatory 4244 34.9 11,341 28.8 8692 32.2 727 29.7 25,004 30.9
Respiratory 952 7.8 4078 10.4 3117 11.6 65 2.7 8212 10.2
Symptoms/signs/ill-defined 603 5.0 343 0.9 39 0.1 340 13.9 1325 1.6
External causes 754 6.2 416 1.1 788 2.9 657 26.9 2615 3.2
Other 1604 13.2 3926 10.0 3553 13.2 275 11.2 9358 11.6
Household
Cohabiting 3231 26.6 21,727 55.2 8692 32.2 240 9.8 33,890 41.9
Living alone 4038 33.2 15,341 39.0 8825 32.7 336 13.7 28,540 35.3
Missingb 4887 40.2 2277 5.8 9445 35.0 1869 76.4 18,478 22.8
Municipality population
0–2000 425 3.5 1472 3.7 767 2.8 123 5.0 2787 3.4
2001–5000 1460 12.0 4733 12.0 2508 9.3 271 11.1 8972 11.1
5001–10,000 1795 14.8 5579 14.2 3381 12.5 354 14.5 11,109 13.7
10,001–50,000 4840 39.8 14,844 37.7 10,504 39.0 903 36.9 31,091 38.4
50,001- 3603 29.6 12,632 32.1 9683 35.9 746 30.5 26,664 33.0
Missingb 33 0.3 85 0.2 119 0.4 48 2.0 285 0.4
Municipality centralityc
Least central 1531 12.6 5129 13.0 2850 10.6 346 14.2 9856 12.2
Less central 858 7.1 2664 6.8 1859 6.9 201 8.2 5582 6.9
Somewhat central 2431 20.0 7651 19.4 4954 18.4 393 16.1 15,429 19.1
Central 7303 60.1 23,816 60.5 17,180 63.7 1457 59.6 49,756 61.5
Missingb 33 0.3 85 0.2 119 0.4 48 2.0 285 0.4
Nursing homed
Yes 1448 11.9 39,945 100.0 7945 29.5 139 5.7 48,877 60.4
No 10,708 88.1 0 0.0 19,017 70.5 2306 94.3 32,031 39.6
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sex, younger age, receiving domiciliary care and living
alone. In total, 41.9% of home deaths and 6.3% of all
deaths were potentially planned. Potentially planned
home deaths were associated with higher age, but
declined in ages above 80 years for people who had
municipal care. Living together with someone was as-
sociated with more potentially planned home deaths
for people with municipal care.
Strengths and limitations
To our knowledge, this is the first study to estimate
number of potentially planned home deaths by using
population-based registry data. The use of routinely
collected data, minimises the burden on patients and
caregivers, associated with primary data collection in
end-of-life care context [24]. The use of death certif-
icates is similar across countries and comparable.
NCoDR provides cause of death for more than 98%
of all deaths in Norway, but has high use of unspe-
cific cause of death codes increasing the risk of mis-
classification. Additionally, few diagnoses are verified
by autopsy [17]. The study accounts for domiciliary
care and nursing home admissions prior to death,
but it is a limitation that we do not have informa-
tion regarding hospital admissions. A methodological
limitation is that we have no exact data on planned
home deaths, but use an indirect approach by an
algorithm. However, there is no registry based infor-
mation source available as an alternative. A limita-
tion for some analyses is that information regarding
whether a person lived alone or together with others
was only available for people who had received mu-
nicipal care. Our definition of a potentially planned
home death may also have led to deaths from acute
illness being classified as potentially planned. More-
over, we cannot exclude that persons with other
Table 1 Distribution of sociodemographic factors and municipal healthcare services by place of death in Norway 2012–2013.*
(Continued)
Place of death
Home Nursing home Hospital Othera Total
n % n % n % n % n %
Domiciliary cared
Yes 7055 58.0 16,455 41.8 15,456 57.3 479 19.6 39,445 48.8
No 5101 42.0 22,890 58.2 11,506 42.7 1966 80.4 41,463 51.2
*Pearson chi-square test: p < 0.001 for all categories
aOther place of death includes abroad, under transportation to hospital, other specified
bNot included in statistical analysis
cClassification based on geographical distance to centre with higher functions
dService any time in the period 0–90 days before death
Fig. 2 Distribution of place of death by age groups
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diagnoses than included in our definition may have
had planned home deaths.
Few potentially planned home deaths
Our data cannot give information regarding a person’s
preference for dying at home. However, we will argue
that our estimation of potentially planned home deaths
in Norway is a valid indication. Planned home death is
not feasible without the support of domiciliary care and
not probable when cause of death is unknown. Even if
there is no preference of dying at home, domiciliary care
in itself signals facilitation of more time at home and in-
creases the probability of dying at home [25]. Thus, the
highest proportion of home deaths that was not random,
and could potentially have been planned, was 56.1% or
8.4% of all deaths in our model. However, it is likely that
Table 2 Adjusted relative risk ratio (RRR) for death at home versus nursing home, and home versus hospitala
Home versus nursing homea Home versus hospitala
Adjusted RRR CI p Adjusted RRR CI p
Sex
Female 0.67 0.64, 0.71 < 0.001 0.97 0.93, 1.02 0.223
Male Ref. Ref.
Age
0–39 49.76 38.34, 64.58 < 0.001 2.21 1.94, 2.51 < 0.001
40–49 19.77 16.55, 23.61 < 0.001 2.61 2.31, 2.96 < 0.001
50–59 11.71 10.55, 12.99 < 0.001 2.38 2.18, 2.60 < 0.001
60–69 7.20 6.68, 7.75 < 0.001 1.91 1.78, 2.04 < 0.001
70–79 2.71 2.55, 2.89 < 0.001 1.32 1.24, 1.41 < 0.001
80–89 Ref. Ref.
90+ 0.55 0.52, 0.59 < 0.001 1.11 1.03, 1.19 0.006
Cause of death
Infectious and parasitic diseases 0.95 0.88, 1.04 0.267 1.03 0.95, 1.12 0.461
Cancer 0.22 0.21, 0.24 < 0.001 0.48 0.45, 0.51 < 0.001
Dementia 0.23 0.20, 0.26 < 0.001 3.18 2.64, 3.82 < 0.001
Circulatory Ref. Ref.
Respiratory 0.51 0.47, 0.56 < 0.001 0.60 0.55, 0.65 < 0.001
Symptoms/signs/ill-defined 3.84 3.29, 4.48 < 0.001 32.21 23.22, 44.71 < 0.001
External causes 1.92 1.66, 2.21 < 0.001 1.55 1.38, 1.74 < 0.001
Other 0.58 0.54, 0.63 < 0.001 0.76 0.71, 0.82 < 0.001
Municipality population
0–2000 1.11 0.97, 1.28 0.135 1.67 1.45, 1.93 < 0.001
2001–5000 1.13 1.03, 1.24 0008 1.73 1.58, 1.93 < 0.001
5001–10,000 1.11 1.02, 1.20 0.014 1.54 1.42, 1.66 < 0.001
10,001–50,000 1.06 1.00, 1.13 0.033 1.30 1.23, 1.37 < 0.001
50,001- Ref. Ref.
Municipality centrality
Least central 0.95 0.87, 1.03 0.227 0.94 0.86, 1.03 0.198
Less central 1.07 0.97, 1 17 0.190 0.90 0.82, 0.99 0.024
Somewhat central 1.02 0.96, 1.09 0.465 1.01 0.95, 1.07 0.839
Central Ref. Ref.
Domiciliary care
Yes 2.70 2.58, 2.83 < 0.001 1.35 1.29, 1.42 < 0.001
No Ref. Ref.
aMultinomial logistic regression with place of death as dependent variable. Number of observations 78,226
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n % n % p n %
All 5089 100 7067 100 80,908 100
Sex < 0.001
Female 2458 48.3 2717 38.5 42,290 52.3
Male 2631 51.7 4350 61.5 38,618 47.7
Age (years) < 0.001
0–39 60 1.2 489 6.9 1841 2.3
40–49 113 2.2 437 6.2 1728 2.1
50–59 367 7.2 882 12.5 4291 5.3
60–69 887 17.4 1494 21.1 9975 12.3
70–79 1115 21.9 1423 20.1 15,053 18.6
80–89 1673 32.9 1620 22.9 29,360 36.3
90+ 874 17.2 722 10.2 18,660 23.1
Cause of deathb < 0.001
Cancer 2225 43.7 423 6.0 21,913 27.1
Circulatory 2071 40.7 2173 30.7 25,004 30.9
Respiratory 602 11.8 350 5.0 8212 10.2
Neurological 155 3.0 48 0.7 1819 2.2
Renal 36 0.7 16 0.2 489 0.6
Other 0 0.0 4057 57.4 23,471 29.0
Household < 0.001
Cohabiting 2273 44.7 958 13.6 33,890 41.9
Living alone 2366 46.5 1672 23.7 28,540 35.3
Missingc 450 8.8 4437 62.8 18,478 22.8
Municipality population < 0.001
0–2000 175 3.4 250 3.5 2787 3.4
2001–5000 651 12.8 809 11.4 8972 11.1
5001–10,000 826 16.2 969 13.7 11,109 13.7
10,001–50,000 2092 41.1 2748 38.9 31,091 38.4
50,001- 1337 26.3 2266 32.1 26,664 33.0
Missingc 8 0.2 25 0.4 285 0.4
Municipality centrality < 0.001
Least central 647 12.7 884 12.5 9856 12.2
Less central 377 7.4 481 6.8 5582 6.9
Somewhat central 1071 21.0 1360 19.2 15,429 19.1
Central 2986 58.7 4317 61.1 49,756 61.5
Missingc 8 0.2 25 0.4 285 0.4
Nursing homed < 0.001
Yes 860 16.9 549 7.8 46,638 57.6
No 4229 83.1 6518 92.2 34,270 42.2
Domiciliary cared < 0.001
Yes 5089 100.0 1966 27.8 39,445 48.8
No 0 0.0 5101 72.2 41,463 51.2
aP Pearson chi-square test for planned and unplanned home deaths
bCause of death was divided into five categories according to diagnoses most likely to receive palliative care, the rest were labelled other
cNot included in statistical analysis
dService any time in the period 0–90 days before death
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the proportion of potentially planned home deaths is
even lower in Norway than our final estimation (41.9%
of home deaths and 6.3% of all deaths), as palliative care
is mostly given to people with cancer [22, 26].
Most research regarding planned home deaths are in-
terventions trying to enable more home deaths, with lit-
tle data on the actual rate of planned home deaths
before the intervention [27]. We found that only 49%
of home deaths from ‘Circulatory disease’ were poten-
tially planned, while 84% of home deaths from
‘Cancer’ were potentially planned. This indicates a
large proportion of sudden or unexpected home
deaths from ‘Circulatory disease’, but could also indi-
cate inequality between these groups in recognition of
palliative care needs [28, 29].
Comparison with previous research
Previous studies have shown that the proportion of
home deaths is associated with low functional status,
preferences on place of death, home care and its in-
tensity, living with relatives, extended family support,
home palliative care, not living in urban areas, higher
socio-economic status and being male [8, 14, 16, 25].
Other factors influencing home death are culture,
ethnicity and number of hospital and nursing home
beds. The relationship with age is more complicated
[8, 14, 16, 25].
We found that living alone was associated with more
home death. This should be interpreted with caution as
we had a large proportion of missing data, but could
indicate a large proportion of unexpected home deaths
Table 4 Odds ratio (OR) for potentially planned home death compared with unplanned home death a
Unadjusted Model 1 Model 2
OR CI p Adjusted OR CI p Adjusted OR CI p
Sex
Female 1.50 (1.39, 1.61) < 0.001 1.29 (1.20, 1.40) < 0.001 0.90 (0.81, 0.99) 0.039
Male Ref. Ref. Ref.
Age
0–39 0.12 (0.09, 0.16) < 0.001 0.14 (0.11, 0.18) < 0.001 0.19 (0.13, 0.26) < 0.001
40–49 0.25 (0.20, 0.31) < 0.001 0.29 (0.23, 0.37) < 0.001 0.41 (0.31, 0.54) < 0.001
50–59 0.40 (0.35, 0.46) < 0.001 0.46 (0.40, 0.53) < 0.001 0.71 (0.59, 0.87) 0.001
60–69 0.57 (0.52, 0.64) < 0.001 0.65 (0.58, 0.72) < 0.001 1.26 (1.07, 1.48) 0.005
70–79 0.76 (0.68, 0.84) < 0.001 0.82 (0.74, 0.91) < 0.001 1.32 (1.14, 1.52) < 0.001
80–89 Ref. Ref. Ref.
90+ 1.17 (1.04, 1.32) 0.009 1.10 (0.97, 1.25) 0.122 0.80 (0.70, 0.92) 0.002
Municipality population
0–2000 1.19 (0.97, 1.46) 0.102 1.29 (1.02, 1.64) 0.032 1.40 (1.01, 1.95) 0.043
2001–5000 1.36 (1.21, 1.54) < 0.001 1.36 (1.17, 1.58) < 0.001 1.40 (1.15, 1.71) 0.001
5001–10,000 1.44 (1.29, 1.62) < 0.001 1.46 (1.28, 1.67) < 0.001 1.47 (1.22, 1.75) < 0.001
10,001–50,000 1.29 (1.18, 1.41) < 0.001 1.27 (1.15, 1.40) < 0.001 1.27 (1.12, 1.44) < 0.001
50,001- Ref. Ref. Ref.
Municipality centrality
Least central 1.06 (0.95, 1.18) 0.321 0.85 (0.74, 0.99) 0.031 0.94 (0.78, 1.15) 0.570
Less central 1.13 (0.98, 1.31) 0.086 0.99 (0.85, 1.16) 0.923 1.02 (0.82, 1.26) 0.868
Somewhat central 1.14 (1.04, 1.25) 0.006 0.99 (0.89, 1.10) 0.877 0.99 (0.86, 1.14) 0.904
Central Ref. Ref. Ref.
Nursing home
Yes 2.44 (2.18, 2.73) < 0.001 2.00 (1.78, 2.25) < 0.001 0.78 (0.68, 0.88) < 0.001
No Ref. Ref. Ref.
Household
Cohabiting 1.68 (1.52, 1.85) < 0.001 1.62 (1.46, 1.80) < 0.001
Living alone Ref. Ref.
aunadjusted, adjusted model 1 for all home deaths (n = 12,123) and adjusted model 2 for persons who had received municipal care (n = 7261)
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for people living alone. However, in a subpopulation of
people who had received municipal care, potentially
planned home deaths were associated with living
together with someone.
There is no consensus definition on rurality, but there
is consistency in associations with place of death across
definitions [30]. We did not find any association with
our definition of rural areas [21], but municipalities with
fewer inhabitants were associated with more home death
compared to hospital and also with more potentially
planned home deaths. This indicates that other factors
than travelling distance to hospitals influence proportion
of home deaths. Home nursing coverage could be a con-
tributing factor, as smaller municipalities in Norway
have better home nursing coverage than larger munici-
palities. The largest cities have higher coverage of long-
term care in institutions and the lowest coverage of
home nursing, which could shift end-of-life care to
nursing homes instead of home [31].
Our results also showed that fewer women died at
home than men. The association was significant when
compared to nursing home, similar to a Swedish
study [9]. A possible explanation could be that women
care for their spouses and live longer, but the association
was present also after adjusting for age and living to-
gether with someone. Another explanation could be that
men have more sudden and unexpected home deaths, as
only men had home deaths from external causes of
death or symptoms/signs/ill-defined and more un-
planned home deaths from circulatory disease. Still, men
had higher odds of a potentially planned home death in
the subpopulation who had received municipal care.
Like many other countries, Norway has experienced
declining home death rates and a shift from hospital
to nursing home deaths [6, 8, 14] . This is partly due
to population aging but also end-of-life care policy
[2–4, 6]. Incongruence between preferred and actual
place of death is common, especially for people with
non-malignant disease [29]. Dying in their preferred
place is considered a quality indicator of care, and
should together with evidence that a majority of
people prefer to die at home, be reflected in future
planning of palliative care services [1, 32].
Transitions in the last phase of life is another important
factor to consider when evaluating quality of end-of-life
care. Transitions in the last months and days before death
are common, with more than half of dying people having
at least one transition [33, 34]. Transitions are shown to
be more common in home-dwelling people, where about
half have a final transition from home to hospital [33, 34].
Groff et al. found an inverse relationship between number
of days in domiciliary care and days spent at home in the
last six months before death, interpreted as doing more of
one thing led to doing more in other areas as well, and did
not necessarily improve patient-centred goals [35].
Although home death will never be a goal or possible for
all dying people, a more person-centred goal like “days
spent at home” could change the perspective of both the
dying person and caregivers and lead to increased time
spent at home in the final phase of life, and together with
palliative homecare reduce symptom burden and increase
chances of home death according to the person’s own
wishes [27, 36, 37].
Conclusions
This registry based study from Norway shows that home
death is relatively infrequent, and by an indirect
algorithm-based definition, we have shown that less than
half of them are potentially planned home deaths. Future
research should investigate how many deaths that are
actually planned to take place at home, and the achieve-
ment of this goal. There is also a need to understand the
transitions in the last phase of life and whether the place
of death corresponds to the patients’ wish, and how
palliative homecare influences such outcomes.
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Abstract
Background: Few studies have estimated planned home deaths compared to actual place of death in a general
population or the longitudinal course of home nursing services and associations with place of death. We aimed to
investigate trajectories of nursing services, potentially planned home deaths regardless of place of death; and
associations of place of death with potentially planned home deaths and nursing service trajectories, by analyzing
data from the last 90 days of life.
Methods: A retrospective longitudinal study with data from the Norwegian Cause of Death Registry and National
registry for statistics on municipal healthcare services included all community-dwelling people who died in Norway
2012–2013 (n = 53,396). We used a group-based trajectory model to identify joint trajectories of home nursing
(hours per week) and probability of a skilled nursing facility (SNF) stay, each of the 13 weeks leading up to death.
An algorithm estimated potentially planned home deaths. We used a multinomial logistic regression model to
estimate associations of place of death with potentially planned home deaths, trajectories of home nursing and
short-term SNF.
Results: We identified four home nursing service trajectories: no (46.5%), accelerating (7.6%), decreasing (22.1%),
and high (23.5%) home nursing; and four trajectories of the probability of a SNF stay: low (69.0%), intermediate
(6.7%), escalating (15.9%), and increasing (8.4%) SNF. An estimated 24.0% of all deaths were potentially planned
home deaths, of which a third occurred at home. Only high home nursing was associated with increased likelihood
of a home death (adjusted relative risk ratio (aRRR) 1.29; CI 1.21–1.38). Following any trajectory with elevated
probability of a SNF stay reduced the likelihood of a home death.
Conclusions: We estimated few potentially planned home deaths. Trajectories of home nursing hours and
probability of SNF stays indicated possible effective palliative home nursing for some, but also missed opportunities
of staying at home longer at the end-of-life. Continuity of care seems to be an important factor in palliative home
care and home death.
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Background
Like Japan, Germany, Italy and Portugal, Norway has de-
clining home death rates, with only 13.3% home deaths
in 2016 [1–6]. Most people, however, express a wish to
receive end-of-life care at home or to die at home [7].
We recently estimated that only about half of the regis-
tered home deaths in Norway may have been planned to
take place at home [8]. Currently, no studies have esti-
mated the number of potentially planned home deaths
in comparison to actual place of death in a general
population.
Specialized community-based palliative homecare ben-
efits patients by increasing the likelihood of dying at
home [9–11], but is unavailable to most dying people
[12]. Specialized palliative care is organized within hos-
pitals and mainly focused on cancer patients [13].
Norway has universal healthcare, and municipalities are
required to provide home nursing services and skilled-
nursing facility care to its inhabitants. Services are avail-
able based on needs, and provided to almost 7% of the
population. Home nursing services are free to the
patient, while skilled nursing facility (SNF) stays have a
deductible based on income. Most SNFs offer some
palliative care [13]. Community-dwelling people may
experience various patterns of home nursing services
and short-term SNF stays before death. Few have in-
vestigated the longitudinal course of home nursing
services and whether it is associated with place of
death [14, 15]. Insight into relationships of these ser-
vices for community-dwelling patients on place of
death may inform policy for end-of-life home-based
services.
We aimed to 1) investigate trajectories of nursing ser-
vices in the last 90 days of life; 2) estimate how many
deaths that potentially could have been planned home
deaths, regardless of actual place of death; and 3) investi-
gate associations between place of death, potentially
planned home deaths and nursing service trajectories, by
analyzing data from the last 90 days of life.
Methods
Study design and data sources
We linked data from the Norwegian Cause of Death
Registry (NCoDR) and the National register for statistics
on municipal healthcare services (IPLOS) and included
all deceased individuals in Norway in 2012–2013 with
known place of death and sex (n = 80,908) (Fig. 1). We
excluded persons in long-term SNFs (n = 27,512) to get
a study population of community-dwelling people.
NCoDR provided information on cause and place of
death, age, sex, and municipality centrality. To ensure
privacy, people 0–39 years were given fewer details for
the cause of death. IPLOS provided information on
cohabitation and municipal nursing and care services
0–90 days before death. Information on cohabitation
was missing for persons never registered in IPLOS.
Measurements
Home nursing and short-term SNF stays
Home nursing includes specific nursing procedures,
such as personal care and daily tasks, drug adminis-
tration, food preparation and general palliative care.
Estimates of the amount of home nursing hours were
based on service decisions provided as mean hours
Fig. 1 Algorithm to indirectly assess deaths that were potentially planned to occur at home, regardless of actual location of death. Deaths in all
locations were assessed (home, hospital, skilled nursing facility, other). Step 1: Cause of death associated with palliative care (y/n). Step 2:
Received home nursing services 7 days before death (y/n)
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per week (hrs/wk) for each of the 13 weeks (0–90
days) leading up to death. People with no home nurs-
ing had 0 hrs/wk. and maximum value indicating care
24/7 was 168 hrs/wk. Short-term SNF stays were
based on service decisions and coded as occurring or
not for each of the 13 weeks leading up to death.
Potentially planned home deaths
Based on previous research we developed an algorithm
to indirectly estimate deaths that could have been
planned to occur at home, regardless of actual location
of death (Fig. 1) [8]. A potentially planned home death
was considered probable for people with a cause of
death most likely to receive palliative care. According to
the European Shortlist for Causes of Death, this was
‘Cancer’ (2.), ‘Heart disease’ (7.0/7.1.2/7.2/7.4; excluding
acute myocardial infarction), ‘Chronic pulmonary dis-
ease’ (8.0/8.3/8.3.1/8.3.2/8.4), ‘Kidney disease’ (12.1) or
‘Neurological disease’ (6.0/6.1/6.3) [16, 17]. Dementia
was not included as almost all Norwegians with demen-
tia die in long-term SNFs [8, 18]. Receiving any home
nursing 7 days before death was considered a require-
ment for a planned home death. Thus, in our algorithm,
a potentially planned home death required a “yes” to
both the following steps of inquiry: Step 1: Was the per-
son’s cause of death associated with palliative care? (y/
n), Step 2: Did the person receive home nursing 7 days
before death? (y/n). The remaining deaths were catego-
rized as unplanned to take place at home, hereafter ‘un-
planned’. To test how sensitive the estimated number of
potentially planned home deaths were to changes in the
home nursing criterium, we evaluated the effects of re-
placing receipt of home nursing within day seven with
receipt of home nursing 14 days before death. As cir-
cumstances may have led to a transition to another loca-
tion before death, we used the above algorithm to assess
deaths in all locations; home, SNF, hospital and other.
Covariates
Cause of death was divided into categories based on diagno-
ses used to define potentially planned home deaths: ‘Cancer’;
‘Heart; ‘Pulmonary’; ‘Kidney’; ‘Neurological’. All other causes
were labeled ‘Other’. We defined seven age-groups; 0–39
years, 10-year intervals up to 89 years, and ≥ 90 years. Muni-
cipality centrality was defined as a municipality’s geographic
location in relation to a center with important central func-
tions, where 0 is least central and 3 most central [19].
Statistical analyses
Decedent characteristics were presented as frequency
and percentages with differences within place of death
tested using Chi-square tests.
We used a group-based, dual-trajectory model to identify
parallel trajectories of home nursing and short-term SNF
stays in the last 13 weeks of life by means of a Stata Traj
plugin [20, 21]. This is a semiparametric finite mixture
model for longitudinal data using a maximum likelihood
method [21]. Hours of home nursing trajectories were
modeled using a censored normal distribution after a log
transformation (log10(home nursing hrs/wk. + 0.1)) to
normalize. We modeled probability of a SNF stay each
week with a Bernoulli distribution. We modeled each out-
come separately, then jointly. Model selection was per-
formed by adding one trajectory at a time followed by
varying higher-order growth terms until an optimal fit was
achieved based on the Bayesian Information Criterion, aver-
age posterior probability of assignment (PPA) (≥0.9 consid-
ered excellent fit), odds of correct classification, the
proportion with PPA < 0.7 (indicated poor fit), and differ-
ences between predicted and observed group proportions
[21]. Group size of 5% was considered a minimum.
Next, we used a multinomial logistic regression to esti-
mate associations of place of death with potentially
planned home deaths, trajectories of home nursing and
short-term SNF. Adjusted relative risk ratio (aRRR) and
their 95% CI was estimated after, adjusting for sex, age
and municipality centrality as potential confounding
factors. Living with others was assessed as a possible
confounder in the population with information on co-
habitation (registered in IPLOS, n = 35,600), without any
indication of this being the case. All analyses were con-
ducted with Stata version 15 (Stata Corp, College
Station, TX). Two-sided p-values < 0.05 were considered
statistically significant.
Results
Characteristics of the population
In our population of community-dwelling people, 54.1%
were men and 85.8% were ≥ 60 years (Table 1). The most
common causes of death were cancer (34.8%) and heart
disease (15.9%). Almost half died in hospitals, nearly a
third in SNFs, and another fifth at home. A higher pro-
portion of men died at home and in hospitals, while
women died more frequently in SNF (Table 1). As ex-
pected, people ≥80 years had a higher proportion of SNF
deaths. Nearly a fifth of home deaths occurred in people
< 60 years. While over half of SNF deaths were from can-
cer, they constituted only a fifth of home deaths. Con-
versely, deaths from heart disease were more common at
home. Ninety days before death 4.9% had a short-term
SNF stay, 42.4% received home nursing services, 8.6% re-
ceived other municipal services, and 44.1% received no
municipal services.
Joint trajectories of home nursing services and
probability of SNF stays
We identified four trajectories of home nursing (hrs/wk)
and four trajectories of the probability of being in a SNF
Kjellstadli et al. BMC Health Services Research          (2019) 19:698 Page 3 of 9
each week. The model, with quadratic growth terms,
was judged to provide an excellent fit to the data, with
PPA ≥0.94 for all trajectories, and clinically interpretable.
The four trajectories for home nursing services are
shown in Fig. 2 (A1-A4):
A1. The largest group of decedents (46.5%) followed a
trajectory of no home nursing services, hereafter called
“no home nursing”.
A2. 7.9% had accelerating home nursing services
starting 9 weeks before death, reaching a median of 1.7
Table 1 Characteristics of 53,396 home-dwelling people who died in Norway 2012–2013 by place of death
Home Nursing home Hospital Othera
n % n % n % n %
Overall population 11,867 22.2 14,895 27.9 24,241 45.4 2393 4.5
Sex
Female 4985 42.0 7827 52.6 11,136 45.9 566 23.7
Male 6882 58.0 7068 47.5 13,105 54.1 1827 76.4
Age (years)
0–39 548 4.6 63 0.4 789 3.3 426 17.8
40–49 549 4.6 165 1.1 719 3.0 263 11.0
50–59 1243 10.5 604 4.1 1854 7.7 389 16.3
60–69 2372 20.0 1860 12.5 4395 18.1 561 23.4
70–79 2505 21.1 3242 21.8 5772 23.8 378 15.8
80–89 3171 26.7 5855 39.3 7827 32.3 314 13.1
90+ 1479 12.5 3106 20.9 2885 11.9 62 2.6
Cause of death
Heart 2456 20.7 1933 13.0 3704 15.3 401 16.8
Cancer 2624 22.1 7629 51.2 8198 33.8 102 4.3
Pulmonary 738 6.2 783 5.3 1874 7.7 44 1.8
Neurological 234 2.0 242 1.6 428 1.8 16 0.7
Kidney 51 0.4 101 0.7 152 0.6 4 0.2
Other 5764 48.6 4207 28.2 9885 40.8 1826 76.3
Householdb
Cohabiting 3067 25.8 6390 42.9 7125 29.4 214 8.9
Living alone 3920 33.0 6906 46.4 7741 31.9 314 13.1
Potentially planned home death
Yes 3471 29.3 2303 15.5 6883 28.4 133 5.6
No 8396 70.8 12,592 84.5 17,358 71.6 2260 94.4
Home nursing trajectory
No 6055 51.0 4921 33.0 11,846 48.9 2036 85.1
Accelerating 872 7.4 1144 7.7 2118 8.7 34 1.4
Decreasing 1536 12.9 5653 38.0 4413 18.2 159 6.6
High 3404 28.7 3177 21.3 5864 24.2 164 6.9
SNF trajectory
Low 10,797 91.0 4204 28.2 19,635 81.0 2320 97.0
Increasing 174 1.5 3462 23.2 901 3.7 20 0.8
Intermediate 601 5.1 1082 7.3 1824 7.5 30 1.3
Escalating 295 2.5 6147 41.3 1881 7.8 23 1.0
Note. Pearson chi-square test comparing place of death: p < 0.001 for all categories
aOther place of death includes abroad, under transportation to hospital, other specified
b17,719 missing household
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hrs/wk. (interquartile range (IQR) 5.8), hereafter called
“accelerating home nursing”.
A3. 22.1% had decreasing home nursing services
starting at a median of 1.0 hrs/wk. (IQR 2.1), hereafter
called “decreasing home nursing”.
A4. 23.5% maintained a high level of home nursing
services with a median of 6.8 hrs/wk. (IQR 9.2) 5 weeks
before death, hereafter called “high home nursing”.
The four trajectories for short-term SNF stays are
shown in Fig. 2 (B1-B4):
B1. 69.0% had a consistently low probability of SNF,
hereafter called “low SNF”.
B2. 6.7% had an intermediate probability of SNF,
hereafter called “intermediate SNF”.
B3. 15.9% had an initial low probability of SNF
escalating from 7 weeks before death, hereafter called
“escalating SNF”.
B4. 8.4% had a trajectory with increasing probability of
SNF, hereafter called “increasing SNF”.
Potentially planned home deaths
We estimated that 12,790 (24.0%) deaths were poten-
tially planned to take place at home (Fig. 1). Receiving
home nursing 14 days instead of 7 days before death,
yielded marginally more (13,603; 25.5%) potentially
planned home deaths, resulting in a higher proportion of
SNF deaths. Actual place of death for the 12,790 poten-
tially planned home deaths was 27.1% home, 18.0% SNF,
53.8% hospital and 1.0% other locations. In total, only
6.5% of all deaths were potentially planned to take place
at home and occurred at home. This corresponds to
15.8% potentially planned home deaths in the entire de-
ceased population in the same period, with 4.3% of all
deaths being potentially planned home deaths that oc-
curred at home.
Comparing potentially planned home deaths and nursing
care trajectories
Nearly half of people with conditions that predicted a
potentially planned home death had high home nursing
services (11.3%) (Fig. 3). An additional 4.7% of the popu-
lation had potentially planned home deaths and acceler-
ating home nursing. Almost all patients with potentially
planned home deaths had a low probability of going to a
nursing home, regardless of which home nursing trajec-
tory they followed. Somewhat unexpectedly, this in-
cluded those with decreasing home nursing. For people
with unplanned home deaths, 4.2 and 4.3% had no home
nursing and followed the increasing or escalating SNF
trajectories, respectively. In general, people with un-
planned home deaths had a larger proportion of people
who followed trajectories with increased probability of
having a short-term SNF stay towards the end-of-life.
Associations between place of death, potentially planned
home deaths and home nursing service trajectories
We found no significant association between death at
home versus hospital or SNF versus hospital and
Fig. 2 Home nursing service trajectories (a) jointly modelled with short-term skilled nursing facility trajectories (b) in the last 13 weeks of life.
Solid lines represent predicted trajectories, dashed lines indicate observed trajectories. Percentage of population for each trajectory are shown.
Home nursing service trajectories were modeled using a censored normal distribution after log transformation. A Bernoulli distribution was used
to model probability of a skilled nursing facility stay each week. In total, 97.1% persons had a probability of assigned trajectory ≥ 0.70
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potentially planned home deaths after adjusting for other
factors (Table 2).
Only people following the high home nursing trajec-
tory had increased likelihood of dying at home com-
pared to hospital (aRRR 1.29, CI 1.21–1.38) (Table 2).
Decreasing home nursing was associated with reduced
likelihood of home death (aRRR 0.90, CI 0.83–0.97),
while no significant association was found for accelerat-
ing home nursing. People following trajectories of high
(aRRR 1.58, CI 1.47–1.70), decreasing (aRRR 1.43, CI
1.34–1.54) and accelerating home nursing (aRRR 1.23,
CI 1.11–1.36) were all more likely to die in a SNF than
hospital. Increasing SNF, escalating SNF and intermedi-
ate SNF were all associated with reduced likelihood of a
home death and higher likelihood of dying in a SNF
compared to hospital. In general, younger age groups
were associated with increased likelihood of dying at
home and less likelihood of SNF deaths compared to
hospital. Those aged ≥90 years were more likely to die
both at home and in SNFs than in hospitals. People liv-
ing in the least central municipalities had the highest
likelihood of dying both at home (aRRR 1.24, CI 1.16–
1.34) and in SNFs (aRRR 1.56, CI 1.45–1.69), compared
to hospitals.
Discussion
We identified four home nursing service trajectories and
four short-term SNF trajectories in the last 3 months of
life in this community-dwelling population. An esti-
mated 24.0% were potentially planned home deaths, of
which a third occurred at home. Half of people with po-
tentially planned home deaths followed the high home
nursing trajectory. Only high home nursing was
associated with increased likelihood of dying at home.
Following any trajectory with elevated probability of a
SNF stay reduced the likelihood of a home death. We
believe we are the first to use trajectory modeling to in-
vestigate patterns of care for home nursing simultan-
eously with short-term SNF stays in the last months of
life and to calculate associations with place of death.
Strengths of our study are the national coverage and
registry-based data. We had access to large numbers of
deaths providing higher power, using state-of-the-art
modelling and had an excellent fit. Universal healthcare
with access to services for all inhabitants in Norway re-
quiring such services, increases validity of our findings.
Limitations include lack of information on hospital ad-
missions, date of admission for hospital deaths, and con-
tacts with family physicians or specialized palliative care
services. As no registry-based information source was
available, we estimated potentially planned home deaths.
While receiving home nursing services seven or 14 days
before death is a narrow definition, this was considered
the latest initiation compatible with building relation-
ships and providing palliative care at home. Almost all
people with potentially planned home deaths started
home nursing at an earlier time. However, we cannot
rule out that some, especially younger people, may have
died at home with support from family caregivers and
possibly hospital-based specialized palliative care. We
could not investigate this further, as information on co-
habitation was only available for those who received mu-
nicipal care. Additionally, we cannot exclude planned
home deaths for other diagnoses than those included in
our definition. The current algorithm led to 3471 (4.3%
of all) home deaths being classified as potentially
Fig. 3 Joint probability of being a member of a specific home nursing service trajectory and a specific short-term skilled nursing facility trajectory
for potentially planned and unplanned home deaths. The probabilities sum up to 100%
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planned compared with 5089 (6.3%) in our previous
publication, because of a refinement of the inclusion cri-
teria [8]. We consider the 24.0% potentially planned
home deaths a valid estimate because palliative care is
mostly offered to cancer patients and planned home
deaths are unlikely without home nursing [17, 22].
People with potentially planned home deaths for the
most part had a low probability of having a short-
term SNF stay and half received high hours of home
nursing. Home nursing service utilization indicates
that time at home and possibly home death was pri-
oritized. People receiving high home nursing was also
the only group with significantly higher likelihood of
home death. A plausible explanation is that people
following this trajectory had high care needs over a
longer period, received home nursing from familiar
caregivers and felt secure staying at home. The evi-
dence from previous studies are conflicting on home
nursing and associations with days spent at home [23,
24], and timing of palliative care [25, 26].
Our findings imply that continuity of services is an im-
portant factor to stay longer at home and die at home.
This is further supported by that we did not find any sig-
nificant association between accelerating home nursing
and home death, although home time seems to have
been prioritized also here. Accelerating home nursing
started closer to death, never reached the number of
hours provided to people receiving high home nursing;
and may in the end have been too little, too late to die
at home. To have continuity and timely start-up of ser-
vices, the patient and family’s preferences of place of
care and death must be known to healthcare providers.
This can be achieved through advance care planning,
which has been shown to both increase chances of dying
at home and improve quality of care [27, 28].
Cancer patients constituted the largest group in all tra-
jectories receiving home nursing. They also more com-
monly have advance care planning [27]. This may be
attributed to cancer having a terminal phase that is eas-
ier to predict [29]. Two-thirds of patients receiving
Table 2 Adjusted relative risk ratios (aRRR) for dying at home, skilled-nursing facility or other location compared to hospital and
their associations with potentially planned home deaths, home nursing trajectories and skilled nursing facility trajectories
Home versus Hospital SNF versus Hospital Othera versus Hospital
aRRR CI p aRRR CI p aRRR CI p
Potentially planned home death (ref. unplanned) 0.94 0.89–1.00 0.066 0.96 0.90–1.03 0.264 0.28 0.23–0.34 < 0.001
Home nursing trajectory (ref. no)
Accelerating 0.93 0.85–1.03 0.168 1.23 1.11–1.36 < 0.001 0.30 0.21–0.43 < 0.001
Decreasing 0.90 0.83–0.97 0.004 1.43 1.34–1.54 < 0.001 0.66 0.55–0.79 < 0.001
High 1.29 1.21–1.38 < 0.001 1.58 1.47–1.70 < 0.001 0.51 0.43–0.61 < 0.001
SNF trajectory (ref. low)
Increasing 0.40 0.34–0.47 < 0.001 17.93 16.43–19.56 < 0.001 0.19 0.12–0.30 < 0.001
Intermediate 0.65 0.59–0.72 < 0.001 2.27 2.08–2.47 < 0.001 0.37 0.26–0.54 < 0.001
Escalating 0.32 0.28–0.36 < 0.001 14.14 13.21–15.14 < 0.001 0.14 0.09–0.22 < 0.001
Female (ref. male) 0.85 0.81–0.89 < 0.001 1.13 1.07–1.19 < 0.001 0.49 0.44–0.54 < 0.001
Age (years) (ref. 80–89)
0–39 1.63 1.45–1.84 < 0.001 0.20 0.15–0.27 < 0.001 7.84 6.61–9.31 < 0.001
40–49 1.80 1.59–2.03 < 0.001 0.57 0.46–0.69 < 0.001 6.22 5.15–7.51 < 0.001
50–59 1.59 1.46–1.83 < 0.001 0.71 0.63–0.80 < 0.001 3.75 3.19–4.41 < 0.001
60–69 1.30 1.22–1.39 < 0.001 0.82 0.75–0.89 < 0.001 2.38 2.04–2.76 < 0.001
70–79 1.06 1.00–1.13 0.060 0.91 0.85–0.97 0.005 1.36 1.16–1.59 < 0.001
90+ 1.20 1.11–1.30 < 0.001 1.55 1.44–1.67 < 0.001 0.66 0.49–0.87 0.003
Municipality centralityb (ref. central)
Least central 1.24 1.16–1.34 < 0.001 1.56 1.45–1.69 < 0.001 1.53 1.34–1.75 < 0.001
Less central 1.06 0.97–1.16 0.205 1.12 1.02–1.24 0.023 1.28 1.09–1.51 0.003
Somewhat central 1.13 1.06–1.20 < 0.001 1.21 1.13–1.29 < 0.001 0.99 0.88–1.12 0.868
Note. Multinomial logistic regression with place of death as dependent variable. Number of observations 53,177
Abbreviations: SNF skilled nursing facility
aOther place of death includes abroad, under transportation to hospital, other specified
bClassification based on geographical distance to center with higher functions
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accelerating home nursing services died from cancer and
fits well with a response to a well-defined trajectory of
rapid functional decline at the end-of-life; mostly attrib-
uted to cancer patients [29]. Yet, another cohort-study
found that most people did not have a distinct trajectory
based on cause of death [30]. There was, however, agree-
ment on substantial functional decline in the last
months of life regardless of diagnosis [29, 30]. So if most
people with a non-sudden death have rapid functional
decline approaching death [29, 30], our findings indicate
many missed opportunities to identify and provide pal-
liative homecare to enable people to stay longer at home;
especially non-cancer patients.
Home death is not feasible for all dying persons,
and for these, transitions to SNF or hospital may be
appropriate. To illustrate, people who received high
home nursing hours and had escalating probability of
a SNF stay most likely represent high care needs over
time where declining function, lack of symptom con-
trol, high caregiver burden or living alone may have
led to a necessary transition. On the other hand, 22%
of decedents followed a trajectory of decreasing home
nursing services. Of these, 50% were already in a SNF
before the last week of life and hence not considered
potentially planned home deaths. Another 40% had a
low joint probability of a SNF stay. More intensive
home nursing services may represent an alternative to
SNF or hospital admission at the end-of-life. A major-
ity never received home nursing services and had low
probability of SNF stays. Some represent sudden or
unexpected deaths, and some younger patients were
probably cared for by family caregivers. Still, it is
likely that a significantly larger proportion could have
benefited from receiving palliative home nursing at an
earlier stage [31].
With increasing demand for palliative care regard-
less of diagnosis, specialized palliative care cannot
alone meet the needs of patients and families [32]. A
recent Swedish study found that a majority of quality
indicators for end-of-life care in the last week of life
were better for patients dying in community-based
settings in regions with less developed palliative care
compared to fully developed palliative care [33]. Gen-
eral palliative care should be provided by all relevant
healthcare personnel, while specialist palliative care
should manage more complex cases [32]. Together
with an involved family physician, home nursing
services could be a viable alternative for providing
general palliative care to people according to their
wishes, regardless of diagnosis [34]. For this to work,
we must also address inadequate policies and guide-
lines, gaps in continuity and coordination of care and
increase the knowledge and skills in palliative end-of-
life care for all health personnel [34–36].
Conclusions
Our estimates show a low number of potentially planned
home deaths in Norway. Trajectories of home nursing
hours and probability of SNF stays indicated possible ef-
fective palliative home nursing for some, but also missed
opportunities of staying at home longer at the end-of-
life. Continuity of care seems to be an important factor
in providing home nursing and dying at home. Transi-
tions from home need further research to ascertain if
current policies maximize time spent at home and in-
crease the likelihood of home deaths. Future studies
should also investigate how family physicians follow up
patients at the end-of-life and whether they can contrib-
ute to an increased number of planned home deaths.
Abbreviations
aRRR: Adjusted relative risk ratio; Hrs/wk.: Hours per week; IPLOS: National
register for statistics on municipal healthcare services; IQR: Interquartile
range; NCoDR: Norwegian Cause of Death Registry; PPA: Average posterior
probability of assignment; SNF: Skilled nursing facility
Acknowledgements
We thank the Norwegian Cause of Death Registry and National registry
(NCoDR) and National registry for statistics on municipal healthcare services
(IPLOS) for providing us with data. We also thank the Biostatistics core at
Program on Aging, Yale University and the Centre for Elderly and Nursing
Home Medicine, University of Bergen, for providing scientific environment.
Author’s contributions
CK contributed to the study design, analysis, interpretation, drafting and
revision of the manuscript. SH contributed to the study design,
interpretation, drafting and revision of the manuscript. LH contributed to
analysis, interpretation and revision of the manuscript. HA contributed to
analysis, interpretation and revision of the manuscript. EF contributed to the
study concept and revised the manuscript. BH contributed to the study
concept and revised the manuscript. All authors read and approved the final
version of the manuscript.
Funding
This work was supported by the Department of Global Health and Primary
Care, University of Bergen; the G.C. Rieber Foundation; and National Centre
for Emergency Primary Health Care, NORCE Norwegian Research Centre to
the project Epidemiology of home death in Norway. This work was supported
by the National Institute on Aging (R01 AG047891-01A1 to H.A.,
P30AG021342-14S1 to H.A.). These analyses were conducted at the Yale
Claude D. Pepper Older Americans Independence Center (P30AG021342).
None of the sources of funding for this study had any involvement in the
design, collection of data, analysis or interpretation of data used in this
manuscript.
Availability of data and materials
The data that support the findings of this study are available from NCoDR
and IPLOS but restrictions apply to the availability of these data, which were
used under license for the current study, and so are not publicly available.
Data are however available from the authors upon reasonable request and
with permission of NCoDR and IPLOS.
Ethics approval and consent to participate
The study was approved by the Regional Committee for Medical and Health
Research Ethics North (2014/2308) and the Norwegian Data Protection
Authority (15/00450–2/CGN, 17/00341–3/SBO). Approvals to access, linkage
and use of registry data was given by the responsible authorities: the




Kjellstadli et al. BMC Health Services Research          (2019) 19:698 Page 8 of 9
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Global Public Health and Primary Care, University of Bergen,
PO Box 7804, N-5018 Bergen, Norway. 2Department of Internal Medicine,
Yale University School of Medicine, 300 George St Suite 775, New Haven, CT
06511, USA. 3Department of Biostatistics, Yale School of Public Health, New
Haven, CT, USA. 4Department of Clinical Psychology, University of Bergen, PO
box 7804, N-5018 Bergen, Norway. 5Municipality of Bergen, Bergen, Norway.
6National Centre for Emergency Primary Health Care, NORCE Norwegian
Research Centre, Bergen, Norway.
Received: 1 March 2019 Accepted: 16 September 2019
References
1. Yang L, Sakamoto N, Marui E. A study of home deaths in Japan from 1951
to 2002. BMC Palliat Care. 2006;5:2.
2. Dasch B, Blum K, Gude P, Bausewein C. Place of death: trends over the
course of a decade: a population-based study of death certificates from the
years 2001 and 2011. Dtsch Arztebl Int. 2015;112:496–504.
3. Costantini M, Balzi D, Garronec E, et al. Geographical variations of place of
death among Italian communities suggest an inappropriate hospital use in
the terminal phase of cancer disease. Public Health. 2000;114:15–20.
4. Sarmento VP, Higginson IJ, Ferreira PL, Gomes B. Past trends and projections
of hospital deaths to inform the integration of palliative care in one of the
most ageing countries in the world. Palliat Med. 2016;30:363–73.
5. Kalseth J, Theisen OM. Trends in place of death: the role of demographic and
epidemiological shifts in end-of-life care policy. Palliat Med. 2017;31:964–74.
6. Norwegian Institute of Public Health. Cause of death, Norway. Table D3 - Deaths
by place of death 2016. http://statistikkbank.fhi.no/dar/. Accessed 19 Feb 2019.
7. Gomes B, Calanzani N, Gysels M, Hall S, Higginson IJ. Heterogeneity and
changes in preferences for dying at home: a systematic review. BMC Palliat
Care. 2013;12:7.
8. Kjellstadli C, Husebo BS, Sandvik H, Flo E, Hunskaar S. Comparing unplanned
and potentially planned home deaths: a population-based cross-sectional
study. BMC Palliat Care. 2018;17:69.
9. Higginson IJ, Finlay IG, Goodwin DM, et al. Is there evidence that palliative
care teams alter end-of-life experiences of patients and their caregivers? J
Pain Symptom Manag. 2003;25:150–68.
10. Seow H, Bainbridge D. A review of the essential components of quality
palliative care in the home. J Palliat Med. 2018;21:S37–44.
11. Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ. Effectiveness and
cost-effectiveness of home palliative care services for adults with advanced
illness and their caregivers. Cochrane Database Syst Rev. 2013;6:CD007760.
12. Pivodic L, Pardon K, Van den Block L, et al. Palliative care service use in four
European countries: a cross-national retrospective study via representative
networks of general practitioners. PLoS One. 2013;8:e84440.
13. Norwegian Directorate of Health. Rapport om tilbudet til personer med behov for
lindrende behandling og omsorg mot livets slutt - å skape liv til dagene [Report
on services to persons in need of palliative care at the end of life – giving life to
the days]. Report IS-2278. Oslo: Norwegian Directorate of Health; 2015.
14. Costa V, Earle CC, Esplen MJ, et al. The determinants of home and nursing home
death: a systematic review and meta-analysis. BMC Palliat Care. 2016;15:8.
15. Gomes B, Higginson IJ. Factors influencing death at home in terminally ill
patients with cancer: systematic review. BMJ. 2006;332:515–21.
16. RAMON – Reference And Management Of Nomenclatures. European Shortlist for
Causes of Death. 2012. https://ec.europa.eu/eurostat/ramon/nomenclatures/
index.cfm?TargetUrl=LST_NOM_DTL&StrNom=COD_2012&StrLanguageCode=
EN&IntPcKey=&StrLayoutCode=HIERARCHIC. Accessed 11 Oct 2019.
17. Melby L, Das A, Halvorsen T, Steihaug S. Evaluering av tjenestetilbudet til
personer med behov for lindrende behandling og omsorg [Evalutaion of
services to persons in need of palliative care]. Report for the Norwegian
directorate of health A27799. Oslo/Trondheim: SINTEF; 2017.
18. Norwegian Institute of Public Health. Halvparten av oss dør i sykehjem [Half
of us die in nursing homes]. https://www.fhi.no/nyheter/2016/halvparten-
av-oss-dor-i-sykehjem/. Accessed 19 Feb 2019.
19. Statistics Norway. Variabeldefinisjon: Sentralitet [Variable definition:
Centrality]. https://www.ssb.no/a/metadata/conceptvariable/vardok/927/nb.
Accessed 19 Feb 2019.
20. Jones BL, Nagin DS. A note on a stata plugin for estimating group-based
trajectory models. Sociol Methods Res. 2013;42:608–13.
21. Nagin DS. Group-based modeling of development. Cambridge: Harvard
University Press; 2005.
22. Cohen J, Beernaert K, Van den Block L, et al. Differences in place of death
between lung cancer and COPD patients: a 14-country study using death
certificate data. NPJ Prim Care Respir Med. 2017;27:14.
23. Seow H, Dhaliwal G, Fassbender K, Rangrej J, Brazil K, Fainsinger R. The
effect of community-based specialist palliative care teams on place of care.
J Palliat Med. 2016;19:16–21.
24. Groff AC, Colla CH, Lee TH. Days spent at home - a patient-centered goal
and outcome. N Engl J Med. 2016;375:1610–2.
25. Grande GE, McKerral A, Addington-Hall JM, Todd CJ. Place of death and use
of health services in the last year of life. J Palliat Care. 2003;19:263–70.
26. Pellizzari M, Hui D, Pinato E, et al. Impact of intensity and timing of
integrated home palliative cancer care on end-of-life hospitalization in
northern Italy. Support Care Cancer. 2017;25:1201–7.
27. Dixon J, King D, Knapp M. Advance care planning in England: is there an
association with place of death? Secondary analysis of data from the
national survey of bereaved people. BMJ Support Palliat Care. 2016;0:1–10.
28. Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance
care planning on end of life care in elderly patients: randomised controlled
trial. BMJ. 2010;340:c1345.
29. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional
decline at the end of life. JAMA. 2003;289:2387–92.
30. Gill TM, Gahbauer EA, Han L, Allore HG. Trajectories of disability in the last
year of life. N Engl J Med. 2010;362:1173–80.
31. Morin L, Aubry R, Frova L, et al. Estimating the need for palliative care
at the population level: a cross-national study in 12 countries. Palliat
Med. 2017;31:526–36.
32. Quill TE, Abernethy AP. Generalist plus specialist palliative care - creating a
more sustainable model. N Engl J Med. 2013;368:1173–5.
33. Schelin ME, Sallerfors B, Rasmussen BH, Furst CJ. Quality of care for the
dying across different levels of palliative care development: a population-
based cohort study. Palliat Med. 2018;32:1596–604.
34. Oishi A, Murtagh FE. The challenges of uncertainty and interprofessional
collaboration in palliative care for non-cancer patients in the community: a
systematic review of views from patients, carers and health-care
professionals. Palliat Med. 2014;28:1081–98.
35. Threapleton DE, Chung RY, Wong SYS, et al. Care toward the end of life in
older populations and its implementation facilitators and barriers: A scoping
review. J Am Med Dir Assoc. 2017;18:1000–1009.e4.
36. Bainbridge D, Seow H, Sussman J. Common components of efficacious in-
home end-of-life care programs: a review of systematic reviews. J Am
Geriatr Soc. 2016;64:632–9.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.




1© The Author(s) 2020. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.  
For commercial re-use, please contact journals.permissions@oup.com
Health Service Research
General practitioners' provision of end-of-life 
care and associations with dying at home: a 
registry-based longitudinal study
Camilla Kjellstadlia,*, , Heather Alloreb,c, , Bettina S. Huseboa,d,  
Elisabeth Floe, Hogne Sandvikf,  and Steinar Hunskaara,f
aDepartment of Global Public Health and Primary Care, University of Bergen, Bergen, Norway, bDepartment of 
Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA, cDepartment of Biostatistics, 
Yale School of Public Health, New Haven, CT, USA, dMunicipality of Bergen, Bergen, Norway, eDepartment of Clinical 
Psychology, University of Bergen, Bergen, Norway and fNational Centre for Emergency Primary Health Care, NORCE 
Norwegian Research Centre, Bergen, Norway
*Correspondence to Camilla Kjellstadli, Department of Global Public Health and Primary Care, University of Bergen, PO Box 
7804, N-5018 Bergen, Norway; Email: camilla.kjellstadli@uib.no
Abstract
Background: General practitioners (GPs) may play an important role in providing end-of-life care 
to community-dwelling people.
Objective: To investigate patients' contacts with GPs, GPs' interdisciplinary collaboration, out-of-
hours services and hospitalizations in the last 13 weeks of life and associations with dying at 
home. Second, investigate whether GP contacts were associated with fewer out-of-hours contacts 
or days hospitalized.
Methods: Individually linked data from the Norwegian Cause of Death Registry, Norwegian 
Patient Registry, Statistics Norway and Control and Payment of Reimbursement to Health Service 
Providers database for all 80  813 deceased people in Norway within 2012–13. Outcomes were 
analyzed with logistic regression and negative binomial multilevel mixed-effect models.
Results: Overall, 1% of people received GP home visits in Week 13 and 4.6% in the last week before 
death. During the last 4 weeks of life, 9.2% received one or more GP home visits. Altogether, 6.6% 
received one or more home visits when the GP had one or more interdisciplinary collaborations 
during the last 4 weeks, of which <3% died at home. GP office consultations decreased towards the 
end of life. The likelihood of home death versus another location increased in relation to GP home 
visits [one home visit odds ratio (OR) 1.92, confidence interval (CI) 1.71–2.15; two or more OR 3.49, 
CI 3.08–3.96] and GP interdisciplinary collaboration (one contact OR 1.76, CI 1.59–1.96; two or more 
OR 2.52, CI 2.32–2.74).
Conclusions: GPs play a role in enabling people to die at home by performing home visits and 
collaborating with other health care personnel. Only a minority received such services in Norway.
Key words: Death/epidemiology, general practice, home visit, palliative care, registries, terminal care.
Background
General practitioners (GPs) may play an important role in providing 
primary end-of-life care to community-dwelling people (1–4). The 
majority of people wish to spend their remaining life at home; how-
ever, specialized palliative care is unavailable for many dying people 
(4–6). Identified quality indicators for appropriate and inappropriate 
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end-of-life care include contacts with the patient's GP, emergency 
department admissions, hospital admissions, late initiation of pal-
liative care and dying at home versus the hospital (7). Factors such 
as palliative care training, recognition of palliative care needs and 
available resources may influence GPs' provision of end-of-life care 
(8,9). GP home visits and interdisciplinary collaboration increase the 
likelihood of home death for cancer patients (1,2,10,11).
In Norway, most citizens are registered with a GP through the 
national health care system (12). Most GPs have long-term patients 
ensuring continuity of care (13). They provide care for patients 
during daytime and out of hours (OOH) for medical emergencies 
in most municipalities; larger cities may have separate 24-hour 
emergency services. GPs are gatekeepers to specialized health care 
services. Together with home nursing services, they are the founda-
tion of primary health care.
Previous studies have provided valuable knowledge about GPs' 
follow-up of patients at the end of life but have mainly used self-
report from GPs and/or focused on cancer patients (2,10,11,14–20). 
These findings are not generalizable to all dying people. We found 
only one previous study reporting GPs' provision of palliative end-
of-life care in a general population while considering hospital and 
emergency department admissions; however, the majority of in-
cluded persons had cancer (1). They did not specify GP contact type 
or consider interdisciplinary collaboration.
We aimed to investigate patients' contacts with GPs (office con-
sultations and home visits), GPs interdisciplinary collaboration, pri-
mary care OOH services, and hospitalizations in the last 13 weeks of 
life for people with all causes of death and how these contacts were 
associated with dying at home in Norway. Second, we investigated 
whether GP contacts were associated with fewer OOH contacts or 
days hospitalized during the last 13 weeks of life.
Methods
We used individually linked data from the Norwegian Cause of 
Death Registry (NCoDR), the Norwegian Patient Registry (NPR), 
Statistics Norway and the Control and Payment of Reimbursement 
to Health Service Providers Database (KUHR) for all decedents in 
Norway within 2012–13 (n = 80 813), excluding those with missing 
information on patient identifier (n = 135), place of death (n = 2484), 
or where country of residence was not Norway (n = 15). Death date 
was set as Day 0 and all events decremented for each day for the last 
13 weeks (3 months).
Outcomes
Place of death provided by NCoDR was grouped into home, 
nursing home (NH), hospital and other (abroad, under transporta-
tion to hospital and other). KUHR provided electronic billing claims 
from GPs and primary care OOH services (hereafter, OOH services). 
For every contact, a claim is made, identifying the physician and the 
patient and gives information about diagnosis and fee codes. OOH 
daytime contacts in Bergen municipality are not included because 
they are not registered in KUHR. Billing claims with errors (n = 42) 
were excluded. This left 307 366 billing claims that were home visits, 
office consultations or contacts with other health care personnel re-
garding the patient (253 663 GPs and 53 703 OOH). We used GP 
contacts with other health care personnel as an indicator of interdis-
ciplinary collaboration (hereafter, interdisciplinary collaboration). 
We defined ‘appropriate follow-up' from GPs at the end of life as 
receiving one or more home visits and one or more interdisciplinary 
collaborations.
NPR provided information on hospital admissions. We excluded 
45 admissions coded as starting after death. For 3923 hospitaliza-
tions, discharge dates after death were set to the day of death.
Covariates
NCoDR provided information about cause of death and age. 
Cause of death was coded according to the International Statistical 
Classification of Diseases, Tenth Revision and grouped into: Cancer 
(C00-D49), Circulatory (I00-I99), Respiratory (J00-J99), Dementia 
(F00-F03, G30), External (V00-Y99) and Other (specified) (21). 
Age was given in 5-year intervals. Statistics Norway provided in-
formation on education, marital status, children and municipality 
centrality. Education indicated highest completed education level, 
categorized as primary school, high school or college/university. 
People with unknown education level were categorized as primary 
school (n = 1422, 2.4%). Marital status was defined as ‘not married' 
if a person was unmarried/widowed/divorced/separated/separated 
partner/divorced partner/surviving partner and defined as ‘married' 
if a person was married/registered partner. Numbers of living chil-
dren of the deceased at the time of death were categorized as 0, 1 
or ≥2. Municipality centrality relates to geographical distance to a 
centre with important functions, categorized from 0 (least central) to 
3 (most central) (22).
Statistical analyses
Characteristics of the population were described as number of 
people and percentages for categorical variables and median and 
25th–75th percentile for continuous variables.
People in long-term NH care receive follow-up from NH phys-
icians instead of their GP. Thus, they are not exposed to GP care 
but remain on their personal GPs' patient list. To account for this, 
we generated the probability of being in long-term care with data 
from the National Registry for statistics on municipal health care 
services (IPLOS) and NCoDR (23). We used factors available in both 
data sets (age, sex, place of death, cause of death main categories 
by European Shortlist for Causes of Death (24), death certificate, 
death abroad, special circumstances, autopsy and police report). The 
model had excellent fit and prediction [receiver operating character-
istic area 0.901 (confidence interval (CI) 0.898–0.903)]. We used this 
predicted probability as a propensity score covariate in the models 
using the NCoDR/NPR/Statistics Norway/KUHR data set.
Logistic regression modeling estimated associations between 
dying at home relative to any other location (NH, hospital and 
other) and factors of interest: number of GP home visits (0, 1, ≥2), 
GP office consultations (0, 1, ≥2), GP interdisciplinary collaboration 
Key messages
• General practitioner (GP) home visits and interdisciplinary collaboration were associated with home death.
• Few received services indicating appropriate end-of-life care from GPs.
• The potential for GPs to deliver this care is currently not utilized.
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(0, 1, ≥2), OOH home visits (0, 1, ≥2), OOH consultations (0, 1, ≥2) 
and days hospitalized, with adjustment for sex, age, cancer, marital 
status, children, education, municipality centrality and probability 
of long-term NH care. We tested whether there was an effect of clus-
tering of patients within each GP's list of patients with a random 
effect of GP. The intra-class correlation of patients within GP was 
very small [intraclass correlation coefficient 0.0014, standard error 
(SE) 0.0057, CI 0.0000004–0.8111]. Consequently, we used a 
multivariable logistic model without clustering. Unadjusted and ad-
justed odds ratios (OR), 95% CIs and P-value are reported.
We estimated associations of GP home visits (0, 1, ≥2), office 
consultations (0, 1, ≥2) and interdisciplinary collaboration (0, 1, ≥2) 
with number of OOH contacts and days hospitalized, separately, 
with negative binomial multilevel mixed-effect models. In these 
models, a random intercept for patients within GP was significant 
and included to account for clustering. Covariates were sex, age, 
cancer, marital status, children, education, municipality centrality, 
probability of long-term NH care, OOH contacts and days hospital-
ized. Results are presented as adjusted incidence rate ratios (IRR), CI 
and P-values. Each cause of death was not included in any regression 
models due to lack of convergence.
Analyses were conducted with Stata version 15 (Stata Corp, 
College Station, TX). Two-sided P-values <0.05 were considered 
statistically significant in all analyses.
Results
Over 2 years, 12 136 people (15%) died at home, half in NHs and 
a third in hospitals (Table 1). Overall, 52% were women. In the ad-
justed model, women were more likely to die at home than men (OR 
1.77, CI 1.66–1.89). In total, 34.7% were married. In the adjusted 
model, married people were less likely to die at home (OR 0.85, 
95% CI 0.79–0.91). Circulatory disease (30.9%) cancer (27.2%) 
and respiratory disease (10.2%) were the most common causes of 
death. During the last 13 weeks of life 14.3% of the population 
received one or more home visits from their GP, 42.7% had one or 
more GP office consultations, 12.0% received one or more home 
visits from OOH services and 20.0% had one or more consultations 
in the OOH clinic. People were hospitalized for a median of 4 days 
(25th–75th percentile 0–14). Overall, 4660 GPs had 79 157 deceased 
people registered, meaning each GP had a median of 15 patients who 
died over 2 years (range 1–86, 25th–75th percentile 8–23).
Weekly contacts with GPs, OOH and hospitalizations 
during the last 13 weeks
The most common primary care contact type was GP office con-
sultations, which decreased towards the end of life (Fig. 1). People 
who received GP home visits increased from 1% of the popula-
tion in Week 13 before death to 4.6% in the last week. We found 
a similar development with a larger proportion of the population 
getting OOH home visits and consultations towards the end of life. 
Percentage of the population hospitalized escalated towards the end 
of life, with 36.8% hospitalized during the last week of life; of which 
9 in 10 died in the hospital.
GP contacts during the last 4 weeks
Overall, 7442 (9.2%) patients received one or more GP home visits 
(range 1–28) in the last 4 weeks of life, 5051 received one (6.3%) 
and 2391 received two or more (3.0%) home visits. Almost a third 
(2.6% of all) of people who received one or more home visit dieds at 
home, while 915 (1.1%) received two or more home visits and died 
at home. Another 6.5% received one or more home visits and died 
in a hospital (3.1%) or NH (3.4%). Furthermore, 6.6% of patients 
received ‘appropriate follow-up' with one or more home visits when 
the GP had one or more interdisciplinary collaborations.
A higher proportion of cancer patients (13.9% within cancer 
diagnosis group) received one or more home visits than those dying 
from respiratory disease (10.0%), circulatory disease (7.3%) or de-
mentia (4.2%; Fig. 2). GP office consultations were more common 
for people dying from circulatory disease (23.0%).
Of the 2653 people (3.3% of population) who died at home from 
cancer, 566 (0.7%) received one home visit and 520 (0.6%) received 
two or more home visits from their GP in the last 4 weeks of life. 
Another 10 768 people (13.3%) died in an NH from cancer; 728 
(0.9%) received one GP home visit and 399 (0.5%) received two 
or more home visits. Additionally, 8461 (10.5%) people died from 
cancer in hospitals, 569 (0.7%) received one and 266 (0.3%) re-
ceived two or more GP home visits.
Associations between home death and patients' 
contacts with GPs, OOH and hospitalizations
GP home visits were associated with dying at home compared to any 
other location in a dose-dependent relationship (one home visit OR 
1.92, CI 1.71–2.15 and two or more OR 3.49, CI 3.08–3.96; Table 
2). There was a dose-dependent association for dying at home with 
GP interdisciplinary collaboration. Both GP office consultations 
and OOH office consultations had dose-dependent association with 
decreased likelihood of home death. Receiving two or more OOH 
home visits was associated with increased odds of home death. 
Likewise, the odds of dying at home decreased by 5% for every day 
hospitalized (OR 0.95, CI 0.94–0.95). In the adjusted model, people 
dying from cancer were less likely to die at home than those dying 
from other conditions (OR 0.12, CI 0.11–0.13).
Associations between GP contacts, OOH contacts 
and days hospitalized
The number of GP home visits, office consultations and interdis-
ciplinary collaborations were associated with patients having an 
OOH contact in a dose-dependent manner (Fig. 3). Having one or 
more GP office consultation or GP interdisciplinary collaboration 
resulted in nearly three more days hospitalized. One GP home visit 
increased IRR of hospitalization resulting in a 1-day increase in 
days hospitalized. Dying from cancer was associated with a reduc-
tion in OOH contacts (IRR 0.86, CI 0.83–0.88) and an increase 
in days hospitalized (IRR 1.93, CI 1.88–1.99), resulting in 6.9 




Our population-based analyses showed that GP home visits and 
interdisciplinary collaboration increased the odds that people died 
at home. People leaving their home for GP consultations or OOH 
contacts or those who were hospitalized were less likely to die at 
home. Overall, 9.2% received home visits during the last 4 weeks of 
life, of which a third died at home. Only 6.6% additionally had GPs 
involved in interdisciplinary collaboration. Over a third of people 
were hospitalized during the last week of life. These findings are 
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important for clinicians and policy makers. Norwegian policies are 
shifting towards care at home at the end of life and possibly home 
death, but the potential for GPs and primary care to deliver this 
care is currently not utilized (25,26). We need a population-based 
strategy for end-of-life care in primary care with a patient-centred 
approach (27).
Strengths and limitations
Strengths of our study are the population-based data with national 
coverage over 2  years. Administrative data, including remuner-
ations from GPs and OOH services reduces self-report bias and 
increases completeness and validity. A large study population with 
little missing information provides high power. Each patient could 
Table 1. Characteristics and health care services in the last 13 weeks of life by place of death for all deceased people in Norway 2012–13.
Home Nursing home Hospital Other Total
n % n % n % n % n %
Total 12 136 15.0 39 349 48.7 26 920 33.3 2408 3.0 80 813 100
Sex
 Female 5166 42.6 23 907 60.8 12 604 46.8 595 24.7 42 272 52.3
 Male 6970 57.4 15 442 39.2 14 316 53.2 1813 75.3 38 541 47.7













 Cancer 2653 21.9 10 768 27.4 8461 31.4 108 4.5 21 990 27.2
 Circulatory 4240 34.9 11 341 28.8 8674 32.2 721 29.9 24 976 30.9
 Respiratory 967 8.0 4082 10.4 3143 11.7 68 2.8 8260 10.2
 Dementia 277 2.3 4958 12.6 213 0.8 11 0.5 5459 6.8
 External 1126 9.3 1201 3.1 1440 5.4 821 34.1 4588 5.7
 Other 2873 23.7 6999 17.8 4989 18.5 679 28.2 15 540 19.2
Education (years)
 Primary school 5622 46.3 19 640 49.9 12 099 44.9 982 40.8 38 343 47.5
 High School 4962 40.9 15 711 39.9 11 311 42.0 1004 41.7 32 988 40.8
 College/university 1552 12.8 3998 10.2 3510 13.0 422 17.5 9482 11.7
Municipality centralitya
 Least central 1531 12.6 5132 13.0 2842 10.6 340 14.1 9845 12.2
 Less central 849 7.0 2661 6.8 1834 6.8 191 7.9 5535 6.9
 Somewhat central 2433 20.1 7736 19.7 4971 18.5 383 15.9 15 523 19.2
 Central 7273 59.9 23 792 60.5 16 988 63.1 1409 58.5 49 462 61.2
Marital statusb
 Not married 7797 64.3 28 214 71.7 15 291 56.8 1491 61.9 52 793 65.3
 Married 4339 35.8 11 135 28.3 11 627 43.2 917 38.1 28 018 34.7
Children alive at time of death
 0 3002 24.7 7661 19.5 5015 18.6 701 29.1 16 379 20.3
 1 1855 15.3 7507 19.1 4421 16.4 370 15.4 14 153 17.5
 ≥2 7279 60.0 24 181 61.5 17 484 65.0 1337 55.5 50 281 62.2
GP home visit
 0 9483 78.1 34 299 87.2 23 153 86.0 2321 96.4 69 256 85.7
 1 1220 10.1 2994 7.6 2420 9.0 53 2.2 6687 8.3
 ≥2 1433 11.8 2056 5.2 1347 5.0 34 1.4 4870 6.0
GP consultation
 0 5264 43.4 29 307 74.5 10 555 39.2 1196 49.7 46 322 57.3
 1 2671 22.0 4374 11.1 5553 20.6 509 21.1 13 107 16.2
 ≥2 4201 34.6 5668 14.4 10 812 40.2 703 29.2 21 384 26.5
GP interdisciplinary collaboration
 0 6516 53.7 24 099 61.2 15 226 56.6 2008 83.4 47 849 59.2
 1 1312 10.8 4870 12.4 3713 13.8 142 5.9 10 037 12.4
 ≥2 4308 35.5 10 380 26.4 7981 29.7 258 10.7 22 927 28.4
Out-of-hours home visits
 0 10 952 90.2 34 420 87.5 23 428 87.0 2336 97.0 71 136 88.0
 1 816 6.7 3696 9.4 2683 10.0 61 2.5 7256 9.0
 ≥2 368 3.0 1233 3.1 809 3.0 11 0.5 2421 3.0
Out-of-hours consultations
 0 10 166 83.8 33 178 84.3 19 187 71.3 2136 88.7 64 667 80.0
 1 1513 12.5 4825 12.3 5722 21.3 186 7.7 12 246 15.2
 ≥2 457 3.8 1346 3.4 2011 7.5 86 3.6 3900 4.8
Days in hospital (median, 
25th–75th percentile)
0.0 (0.0–5.0) 0.0 (0.0–10.0) 11.0 (4.0–22.0) 0.0 (0.0–0.0) 4.0 (0.0–14.0)
aMunicipality centrality missing for 448 individuals.
bMarital status missing for two individuals.
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be linked to their individual GP, thus accounting for variations ex-
plained by differences between GPs. This is the first quantification of 
GPs' follow-up of dying patients.
Limitations include lack of information about home nursing 
services and NH admissions. We partly accounted for home nursing 
by investigating GPs' interdisciplinary collaboration, which is pre-
dominantly with home nursing services. People with long-term NH 
care are retained on the GPs' patient list and were not excluded 
but accounted for with a prediction model for the probability of 
long-term care based on previous data (23,28). We could not as-
certain whether OOH contacts or hospital admissions were appro-
priate. We could not account for outpatient specialized palliative 
care. The number of hospital admissions for palliative care was neg-
ligible. Administrative data cannot investigate the quality of health 
care services provided to people. We controlled for some socio-
demographics; other factors may influence the ability to remain at 
home. Our findings may be generalized to similar health care systems 
with GPs providing continuity of care.
Comparison with previous research
Bringing patients out of their home for health care services in the GP 
office, OOH clinic or hospital reduced the odds of dying at home in 
a dose-dependent manner. Conversely, more GP home visits and GP 
interdisciplinary collaboration was associated with dying at home. 
Figure 1. Percentage of all deceased with one or more of contact types: GP home visit, GP office consultation, OOH home visit, OOH consultations and/or 
hospitalization each week in the last 13 weeks of life.
Figure 2. Percent of patients receiving GP home visits, office consultations and GP interdisciplinary collaboration in the last 4 weeks of life for the most common 
causes of death. Columns represent percent of patients within each of the four most common cause of death diagnosis groups.
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Both are associated with appropriate palliative end-of-life care 
from GPs (7,29) and agree with previous studies on cancer patients 
(2,10,16). Although home visits increased towards the end of life, in 
total, few dying people received this service from their GP. Previous 
studies have found large differences between GPs in performing 
home visits, with up to a quarter not involving themselves in pallia-
tive care (9,16). Reasons for not providing palliative care included 
not only organizational factors, such as limited resources and time, 
but also the GP's lack of knowledge and training in palliative care, 
not recognizing people needing palliative care and lack of interest or 
having to make home visits (8,9). GPs are required to make home 
visits to patients who are unable to have office consultations or to 
provide responsible health care according to Norwegian regulations 
(30). More people could benefit from follow-up from their GP at 
the end of life as 38–75% of dying people need palliative care (31). 
The UK is one of several countries with increasing number of home 
deaths and improved care due to systematic work to improve pallia-
tive care at all health care levels on both a population and personal 
level (27,32). In primary care, systematic quality improvement to 
enhance proactive person-centred end-of-life care by enabling earlier 
identification, better needs assessment, planning and coordination 
to meet preferences of patients nearing the end of life has led to im-
proved outcomes (33).
Only 6.6% received appropriate GP follow-up with home visits 
and interdisciplinary collaboration during the last 4 weeks. We pre-
viously found that only a continuously high level of home nursing 
services towards the end of life was associated with people dying at 
home, and home nursing appeared protective of NH admission (28). 
Overall, 7.5% received high levels of home nursing and were esti-
mated to have a death potentially planned to occur at home; similar 
to the proportion of people receiving appropriate GP follow-up (28). 
Key elements for staying at home appear to be continuity of care, ap-
propriate services and interdisciplinary collaboration.
Less than 3% of people received appropriate follow-up from 
their GP and died at home. This is lower than previous estimations 
of 4.3–6.3% of dying people with home deaths potentially planned 
to occur at home, based on cause of death and home nursing services 
(23,28), and far from the 15% who died at home. Numbers of home 
deaths are influenced by national policies, organization of health care 
services and family circumstances. It can be challenging to use home 
deaths as an indicator of appropriate end-of-life care. Even when 
end-of-life care is provided, various conditions, such as symptom 
burden or acute symptoms, may lead to a proper transition to an-
other location before death (2,34). Some home deaths are sudden or 
unexpected and, thus, not offered palliative care.
More GP contacts were associated with more OOH contacts 
and more days hospitalized. This could be related to patients having 
a high symptom burden and frequent need of health care services 
(2). Receiving two or more GP home visits was not associated with 
hospitalization length, which could indicate that a certain inten-
sity of home visits is needed to reduce hospitalizations. A Danish 
study found that more home visits reduced hospitalization length for 
cancer patients (16). Interestingly, GPs are only involved in 26–46% 
of hospitalizations of patients (34,35). The rest are initiated by OOH 
services, patients and/or families, outpatient clinics or agreement dir-
ectly with hospital wards (34,35).
Cancer patients had the highest proportion of home visits and 
interdisciplinary collaboration but died infrequently at home. The 
low proportion of cancer home deaths in Norway can be attributed 
to organizational factors and access to specialized palliative care in 
hospitals (36,37). Although primary palliative care is provided to 
a more diverse group (37), our results support that cancer patients 
receive more palliative care from GPs than organ failure patients 
(4). Reasons include that GPs identify patients with palliative care 
needs late and based on clinical judgement, leading to late initiation 
of palliative end-of-life care or none at all, especially for non-cancer 
patients (38,39).
Conclusions
GPs play an important role in enabling people to die at home by 
performing home visits and collaborating with other health care per-
sonnel but only for a small minority of dying people in Norway. Most 
people did not receive services indicating appropriate end-of-life care 
Table 2. OR for home death compared to any other location of death (nursing home, hospital and other) and associations with contacts 
with GPs, OOH and days spent in hospital during the last 13 weeks of life for all deceased people in Norway 2012–13
Unadjusted Adjusted
OR CI P Adjusted OR CI P
GP home visit (ref. 0)
 1 1.41 1.32–1.50 <0.001 1.92 1.71–2.15 <0.001
 ≥2 2.63 2.46–2.81 <0.001 3.49 3.08–3.96 <0.001
GP office consultation (ref. 0)
 1 2.00 1.90–2.10 <0.001 0.87 0.80–0.94 0.001
 ≥2 1.91 1.82–1.99 <0.001 0.80 0.74–0.86 <0.001
GP interdisciplinary collaboration (ref. 0)
 1 0.95 0.90–1.02 0.146 1.76 1.59–1.96 <0.001
 ≥2 1.47 1.41–1.53 <0.001 2.52 2.32–2.74 <0.001
Out-of-hours home visits (ref. 0)
 1 0.70 0.65–0.75 <0.001 1.04 0.92–1.17 0.553
 ≥2 0.99 0.88–1.10 0.793 1.26 1.03–1.54 0.024
Out-of-hours consultations (ref. 0)
 1 0.76 0.71–0.80 <0.001 0.85 0.77–0.92 <0.001
 ≥2 0.71 0.64–0.79 <0.001 0.78 0.67–0.90 0.001
Hospital days 0.95 0.94–0.95 <0.001 0.95 0.94–0.95 <0.001
Logistic regression with home death relative to any other location (nursing home, hospital and other) as dependent variable. Covariates adjusted for: sex, age, 
cancer, marital status, children, education, municipality centrality and probability of receiving long-term nursing home care. Number of observations: 80 365.
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at home from GPs. We need to investigate mechanisms behind suc-
cessful follow-up from GPs at the end of life and how it can be avail-
able for more people.
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